LKB1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Y Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| O14744 | T132 | GPS6|PSP | PRMT5 HRMT1L5 IBP72 JBP1 SKB1 | NFGAYLGLPAFLLPLNQEDNtNLARVLtNHIHtGHHSSMFW |
| O14744 | T139 | GPS6|SIGNOR|PSP | PRMT5 HRMT1L5 IBP72 JBP1 SKB1 | LPAFLLPLNQEDNtNLARVLtNHIHtGHHSSMFWMRVPLVA |
| O14744 | T144 | GPS6|SIGNOR|PSP | PRMT5 HRMT1L5 IBP72 JBP1 SKB1 | LPLNQEDNtNLARVLtNHIHtGHHSSMFWMRVPLVAPEDLR |
| O14818 | T147 | Sugiyama | PSMA7 HSPC | FGISALIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKS |
| O14818 | T152 | Sugiyama | PSMA7 HSPC | LIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVREFL |
| O14818 | Y145 | Sugiyama | PSMA7 HSPC | RPFGISALIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGA |
| O43390 | T134 | Sugiyama | HNRNPR HNRPR | KVQESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDS |
| O43852 | T89 | Sugiyama | CALU | sKERLGKIVSKIDGDKDGFVtVDELKDWIKFAQKRWIyEDV |
| O60285 | T211 | GPS6|SIGNOR|ELM|EPSD|PSP | NUAK1 ARK5 KIAA0537 OMPHK1 | NIKIADFGLSNLYQKDKFLQtFCGSPLYASPEIVNGRPYRG |
| O60506 | T131 | Sugiyama | SYNCRIP HNRPQ NSAP1 | KVADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDS |
| O75821 | T190 | Sugiyama | EIF3G EIF3S4 | PYKDtLGPMQKELAEQLGLstGEKEKLPGELEPVQAtQNKt |
| O95218 | S181 | Sugiyama | ZRANB2 ZIS ZNF265 | DEDLsKyKLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRR |
| O95757 | S599 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | sIDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERND |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P04040 | S515 | Sugiyama | CAT | ALLDKYNAEKPKNAIHtFVQsGsHLAAREKANL________ |
| P04040 | S517 | Sugiyama | CAT | LDKYNAEKPKNAIHtFVQsGsHLAAREKANL__________ |
| P04040 | T29 | Sugiyama | CAT | SDQMQHWKEQRAAQKADVLttGAGNPVGDKLNVItVGPRGP |
| P04040 | T511 | Sugiyama | CAT | SHIQALLDKYNAEKPKNAIHtFVQsGsHLAAREKANL____ |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04637 | S15 | SIGNOR|EPSD|PSP | TP53 P53 | ______MEEPQsDPsVEPPLsQEtFsDLWKLLPENNVLsPL |
| P04637 | S392 | SIGNOR|EPSD|PSP | TP53 P53 | KKGQstsRHKKLMFKtEGPDsD___________________ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04792 | T174 | Sugiyama | HSPB1 HSP27 HSP28 | SSsLsPEGtLTVEAPMPKLAtQsNEItIPVtFEsRAQLGGP |
| P05198 | T281 | Sugiyama | EIF2S1 EIF2A | KIEEKRGVFNVQMEPKVVtDtDEtELARQMERLERENAEVD |
| P06733 | S27 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | HAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEAL |
| P06733 | T19 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | __MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGA |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | T26 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEA |
| P06733 | T41 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKG |
| P06744 | T248 | Sugiyama | GPI | WFLQAAKDPSAVAKHFVALstNttKVKEFGIDPQNMFEFWD |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07237 | T453 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | EAVKVHsFPtLKFFPAsADRtVIDyNGERtLDGFKKFLESG |
| P07814 | S1511 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PGAKCVCGKNPAKyytLFGRsy___________________ |
| P08195 | T599 | Sugiyama | SLC3A2 MDU1 | QASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEPH |
| P08238 | T85 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtI |
| P08238 | T89 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtIAKSG |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P0DPH7 | T51 | Sugiyama | TUBA3C TUBA2 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P0DPH7 | T56 | Sugiyama | TUBA3C TUBA2 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVVD |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T47 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtNtV |
| P11940 | T191 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | GRFKSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLF |
| P11940 | T319 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KNLDDGIDDERLRKEFsPFGtItsAKVMMEGGRSKGFGFVC |
| P11940 | T321 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | LDDGIDDERLRKEFsPFGtItsAKVMMEGGRSKGFGFVCFs |
| P13639 | T5 | Sugiyama | EEF2 EF2 | ________________MVNFtVDQIRAIMDKKANIRNMsVI |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14618 | T45 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | TFLEHMCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMI |
| P14618 | T50 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | MCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMIKsGMN |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15880 | S281 | Sugiyama | RPS2 RPS4 | FtKsPyQEFtDHLVKtHtRVsVQRtQAPAVATt________ |
| P17066 | T49 | Sugiyama | HSPA6 HSP70B' | EILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHNtV |
| P18124 | T170 | Sugiyama | RPL7 | VNELIyKRGYGKINKKRIALtDNALIARSLGKyGIICMEDL |
| P18669 | T146 | Sugiyama | PGAM1 PGAMA CDABP0006 | MEPDHPFysNIsKDRRyADLtEDQLPsCEsLKDtIARALPF |
| P18669 | T159 | Sugiyama | PGAM1 PGAMA CDABP0006 | DRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQIKEGK |
| P19338 | T464 | Sugiyama | NCL | KTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWsGE |
| P20042 | T163 | Sugiyama | EIF2S2 EIF2B | DEALEDEDNKKDDGIsFsNQtGPAWAGSERDytyEELLNRV |
| P20618 | S157 | Sugiyama | PSMB1 PSC5 | IIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLL |
| P22314 | T233 | Sugiyama | UBA1 A1S9T UBE1 | GEQPLSAMVSMVTKDNPGVVtCLDEARHGFESGDFVSFSEV |
| P22626 | T140 | Sugiyama | HNRNPA2B1 HNRPA2B1 | KEDTEEHHLRDyFEEYGKIDtIEIItDRQsGKKRGFGFVtF |
| P23284 | T81 | Sugiyama | PPIB CYPB | IFGLFGKTVPKTVDNFVALAtGEKGFGYKNSKFHRVIKDFM |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P25786 | T11 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | __________MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQ |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26599 | T138 | PSP | PTBP1 PTB | TPVLRGQPIyIQFsNHKELKtDSSPNQARAQAALQAVNSVQ |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27448 | S215 | SIGNOR|EPSD|PSP | MARK3 CTAK1 EMK2 | ADFGFSNEFTVGGKLDtFCGsPPYAAPELFQGKKYDGPEVD |
| P27448 | T211 | GPS6|SIGNOR|EPSD|PSP | MARK3 CTAK1 EMK2 | NIKIADFGFSNEFTVGGKLDtFCGsPPYAAPELFQGKKYDG |
| P29401 | T444 | Sugiyama | TKT | DGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAANT |
| P30041 | T48 | Sugiyama | PRDX6 AOP2 KIAA0106 | FLGDSWGILFSHPRDFtPVCttELGRAAKLAPEFAKRNVKL |
| P30050 | T135 | Sugiyama | RPL12 | QMRHRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDI |
| P30086 | T69 | Sugiyama | PEBP1 PBP PEBP | RPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREWHHFLV |
| P30419 | T122 | Sugiyama | NMT1 NMT | GQGPAKTMEEASKRSyQFWDtQPVPKLGEVVNtHGPVEPDK |
| P34931 | T49 | Sugiyama | HSPA1L | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQNTV |
| P35579 | S1308 | Sugiyama | MYH9 | LLsQsDSKSSKLTKDFsALEsQLQDtQELLQEENRQKLsLs |
| P35579 | T1313 | Sugiyama | MYH9 | DSKSSKLTKDFsALEsQLQDtQELLQEENRQKLsLstKLKQ |
| P35579 | T1764 | Sugiyama | MYH9 | NtELINDRLKKANLQIDQINtDLNLERSHAQKNENARQQLE |
| P35579 | T1904 | Sugiyama | MYH9 | EEAQRANAsRRKLQRELEDAtEtADAMNREVssLKNKLRRG |
| P35579 | T1906 | Sugiyama | MYH9 | AQRANAsRRKLQRELEDAtEtADAMNREVssLKNKLRRGDL |
| P36578 | S63 | Sugiyama | RPL4 RPL1 | NLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGG |
| P36578 | T62 | Sugiyama | RPL4 RPL1 | TNLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGG |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | T86 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | CVAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAK |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P38936 | T80 | PSP | CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1 | EGDFAWERVRGLGLPKLyLPtGPRRGRDELGGGRRPGtsPA |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P40429 | T155 | Sugiyama | RPL13A | FAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYRKKKQLM |
| P41091 | T22 | Sugiyama | EIF2S3 EIF2G | AGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAtI |
| P41091 | T430 | Sugiyama | EIF2S3 EIF2G | sLstGGRVSAVKADLGKIVLtNPVCtEVGEKIALSRRVEKH |
| P41091 | T435 | Sugiyama | EIF2S3 EIF2G | GRVSAVKADLGKIVLtNPVCtEVGEKIALSRRVEKHWRLIG |
| P43490 | T179 | Sugiyama | NAMPT PBEF PBEF1 | ITVATNSREQKKILAKyLLEtsGNLDGLEyKLHDFGyRGVS |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46778 | T29 | Sugiyama | RPL21 | RGTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQ |
| P46937 | S127 | PSP | YAP1 YAP65 | QAstDAGtAGALtPQHVRAHssPAsLQLGAVsPGtLtPtGV |
| P48643 | T269 | Sugiyama | CCT5 CCTE KIAA0098 | AILTCPFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMI |
| P48741 | T49 | Sugiyama | HSPA7 HSP70B | EILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHNtV |
| P50991 | T201 | Sugiyama | CCT4 CCTD SRB | SLLsPMSVNAVMKVIDPAtAtsVDLRDIKIVKKLGGTIDDC |
| P50991 | T50 | Sugiyama | CCT4 CCTD SRB | PAQIRFsNISAAKAVADAIRtsLGPKGMDKMIQDGKGDVtI |
| P54646 | T172 | GPS6|SIGNOR|EPSD|PSP | PRKAA2 AMPK AMPK2 | NAKIADFGLSNMMsDGEFLRtsCGsPNyAAPEVISGRLYAG |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | T48 | Sugiyama | HSPA2 | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTNTI |
| P57059 | T182 | GPS6|SIGNOR|ELM|EPSD|PSP | SIK1 SIK SNF1LK | DIKLADFGFGNFYKSGEPLStWCGsPPYAAPEVFEGKEYEG |
| P60174 | T38 | Sugiyama | TPI1 TPI | RKQsLGELIGtLNAAKVPADtEVVCAPPtAyIDFARQKLDP |
| P60174 | T46 | Sugiyama | TPI1 TPI | IGtLNAAKVPADtEVVCAPPtAyIDFARQKLDPKIAVAAQN |
| P60174 | T90 | Sugiyama | TPI1 TPI | VTNGAFtGEIsPGMIKDCGAtWVVLGHsERRHVFGEsDELI |
| P60484 | S380 | SIGNOR|EPSD|PSP | PTEN MMAC1 TEP1 | SSsTSVtPDVsDNEPDHyRYsDttDsDPENEPFDEDQHtQI |
| P60484 | S385 | SIGNOR|iPTMNet|EPSD | PTEN MMAC1 TEP1 | VtPDVsDNEPDHyRYsDttDsDPENEPFDEDQHtQItKV__ |
| P60484 | T382 | GPS6|SIGNOR|ELM|EPSD|PSP | PTEN MMAC1 TEP1 | sTSVtPDVsDNEPDHyRYsDttDsDPENEPFDEDQHtQItK |
| P60484 | T383 | SIGNOR|EPSD|PSP | PTEN MMAC1 TEP1 | TSVtPDVsDNEPDHyRYsDttDsDPENEPFDEDQHtQItKV |
| P60660 | T22 | Sugiyama | MYL6 | CDFTEDQTAEFKEAFQLFDRtGDGKILysQCGDVMRALGQN |
| P60660 | T85 | Sugiyama | MYL6 | LDFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVM |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61978 | Y72 | Sugiyama | HNRNPK HNRPK | KNAGAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISA |
| P62241 | S160 | Sugiyama | RPS8 OK/SW-cl.83 | KRSKKIQKKYDERKKNAKIssLLEEQFQQGKLLACIASRPG |
| P62263 | T133 | Sugiyama | RPS14 PRO2640 | QsALRALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL__ |
| P62266 | T34 | Sugiyama | RPS23 | RSHRRDQKWHDKQYKKAHLGtALKANPFGGAsHAKGIVLEK |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62750 | T42 | Sugiyama | RPL23A | LKAKKAVLKGVHSHKKKKIRtsPTFRRPKTLRLRRQPKYPR |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62906 | T9 | Sugiyama | RPL10A NEDD6 | ____________MSSKVsRDtLyEAVREVLHGNQRKRRKFL |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | T146 | Sugiyama | RPL8 | LARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVISSANRAVV |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P62979 | S134 | Sugiyama | RPS27A UBA80 UBCEP1 | IsRLRRECPsDECGAGVFMAsHFDRHyCGKCCLtyCFNKPE |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | T126 | Sugiyama | YBX1 NSEP1 YB1 | GEtVEFDVVEGEKGAEAANVtGPGGVPVQGsKYAADRNHYR |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68104 | T261 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P68363 | T51 | Sugiyama | TUBA1B | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P68363 | T56 | Sugiyama | TUBA1B | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T80 | Sugiyama | TUBA1B | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| P83731 | S7 | Sugiyama | RPL24 | ______________MKVELCsFsGyKIYPGHGRRYARTDGK |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| Q00839 | T530 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | KTTWVTKHAAENPGKyNILGtNtIMDKMMVAGFKKQMADtG |
| Q00839 | T582 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | CLGKFIEIAARKKRNFILDQtNVsAAAQRRKMCLFAGFQRK |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01105 | S165 | Sugiyama | SET | PyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQ |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q05639 | T261 | Sugiyama | EEF1A2 EEF1AL STN | PTDKPLRLPLQDVyKIGGIGtVPVGRVETGILRPGMVVTFA |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q06830 | T166 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | DLPVGRsVDEtLRLVQAFQFtDKHGEVCPAGWKPGsDtIKP |
| Q06830 | T18 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | ___MSSGNAKIGHPAPNFKAtAVMPDGQFKDIsLsDyKGKY |
| Q07020 | T136 | Sugiyama | RPL18 | AGGKILtFDQLALDsPKGCGtVLLsGPRKGREVYRHFGKAP |
| Q07020 | T85 | Sugiyama | RPL18 | RMIRKMKLPGRENKtAVVVGtItDDVRVQEVPKLKVCALRV |
| Q07020 | T87 | Sugiyama | RPL18 | IRKMKLPGRENKtAVVVGtItDDVRVQEVPKLKVCALRVTS |
| Q13131 | T183 | GPS6|SIGNOR|EPSD|PSP | PRKAA1 AMPK1 | NAKIADFGLsNMMsDGEFLRtsCGsPNyAAPEVISGRLYAG |
| Q13153 | T109 | SIGNOR|EPSD|PSP | PAK1 | FDAVTGEFTGMPEQWARLLQtsNITKsEQKKNPQAVLDVLE |
| Q13283 | S250 | Sugiyama | G3BP1 G3BP | sssPAPADIAQtVQEDLRtFsWAsVtsKNLPPSGAVPVTGI |
| Q13283 | T241 | Sugiyama | G3BP1 G3BP | ETAPEDAQKsssPAPADIAQtVQEDLRtFsWAsVtsKNLPP |
| Q13283 | T255 | Sugiyama | G3BP1 G3BP | PADIAQtVQEDLRtFsWAsVtsKNLPPSGAVPVTGIPPHVV |
| Q13310 | T191 | Sugiyama | PABPC4 APP1 PABP4 | GRFKSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELF |
| Q13485 | T77 | EPSD|PSP | SMAD4 DPC4 MADH4 | LITAITTNGAHPSKCVTIQRtLDGRLQVAGRKGFPHVIYAR |
| Q14444 | T303 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | YTEQSEVESTEYVNRQFMAEtQFtsGEKEQVDEWTVETVEV |
| Q14677 | S164 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | RLREERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKW |
| Q14677 | T271 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | KDEEETVTTKHIHItQATEttttRHKRTANPsKtIDLGAAA |
| Q14680 | T167 | GPS6|SIGNOR|ELM|EPSD|PSP | MELK KIAA0175 | KLIDFGLCAKPKGNKDyHLQtCCGsLAYAAPELIQGKSYLG |
| Q15080 | S67 | Sugiyama | NCF4 SH3PXD4 | TKGGSKYLIYRRYRQFHALQsKLEERFGPDSKSSALACTLP |
| Q15293 | T100 | Sugiyama | RCN1 RCN | sKERLGKIVDRIDNDGDGFVttEELKtWIKRVQKRyIFDNV |
| Q15831 | S307 | Sugiyama | STK11 LKB1 PJS | KGMLEYEPAKRFSIRQIRQHsWFRKKHPPAEAPVPIPPsPD |
| Q15831 | S31 | Sugiyama | STK11 LKB1 PJS | MFTEGELMSVGMDTFIHRIDstEVIYQPRRKRAKLIGKYLM |
| Q15831 | S325 | Sugiyama | STK11 LKB1 PJS | QHsWFRKKHPPAEAPVPIPPsPDTKDRWRsMtVVPYLEDLH |
| Q15831 | S428 | EPSD|PSP | STK11 LKB1 PJS | GRAPNPARKACSASSKIRRLsACKQQ_______________ |
| Q15831 | S69 | Sugiyama | STK11 LKB1 PJS | YLMGDLLGEGSYGKVKEVLDsETLCRRAVKILKKKKLRRIP |
| Q15831 | T185 | SIGNOR|EPSD|PSP | STK11 LKB1 PJS | EYLHSQGIVHKDIKPGNLLLtTGGtLKISDLGVAEALHPFA |
| Q15831 | T189 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | STK11 LKB1 PJS | SQGIVHKDIKPGNLLLtTGGtLKISDLGVAEALHPFAADDT |
| Q15831 | T32 | Sugiyama | STK11 LKB1 PJS | FTEGELMSVGMDTFIHRIDstEVIYQPRRKRAKLIGKYLMG |
| Q15831 | T336 | GPS6|SIGNOR|EPSD|PSP | STK11 LKB1 PJS | AEAPVPIPPsPDTKDRWRsMtVVPYLEDLHGADEDEDLFDI |
| Q15831 | T363 | GPS6|SIGNOR|EPSD|PSP | STK11 LKB1 PJS | DLHGADEDEDLFDIEDDIIYtQDFtVPGQVPEEEASHNGQR |
| Q15831 | T395 | Sugiyama | STK11 LKB1 PJS | EEASHNGQRRGLPKAVCMNGtEAAQLStKSRAEGRAPNPAR |
| Q15831 | T402 | SIGNOR|EPSD|PSP|Sugiyama | STK11 LKB1 PJS | QRRGLPKAVCMNGtEAAQLStKSRAEGRAPNPARKACSASS |
| Q2VIR3 | T22 | Sugiyama | EIF2S3B | AGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAtI |
| Q2VIR3 | T430 | Sugiyama | EIF2S3B | sLstGGRVSAVKADLGKIVLtNPVCtEVGEKIALSRRVEKH |
| Q2VIR3 | T435 | Sugiyama | EIF2S3B | GRVSAVKADLGKIVLtNPVCtEVGEKIALSRRVEKHWRLIG |
| Q562R1 | T107 | Sugiyama | ACTBL2 | WYHTFYNELRVAPDEHPILLtEAPLNPKINREKMTQIMFEA |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q5H9R7 | S579 | Sugiyama | PPP6R3 C11orf23 KIAA1558 PP6R3 SAPL SAPS3 | IDQFGFNDEKFADQDDIGNVsFDRVSDINFTLNTNESGNIA |
| Q5VTE0 | T261 | Sugiyama | EEF1A1P5 EEF1AL3 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q684P5 | S544 | Sugiyama | RAP1GAP2 GARNL4 KIAA1039 RAP1GA2 | PGSLSGGISHNSMEVTKtTFsPPVVAATVKNQSRSPIKRRS |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6PEY2 | T51 | Sugiyama | TUBA3E | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q6PEY2 | T56 | Sugiyama | TUBA3E | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVVD |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6UUV9 | S151 | PSP | CRTC1 KIAA0616 MECT1 TORC1 WAMTP1 | CPYGTMYLsPPADTSWRRtNsDsALHQstMtPtQPEsFssG |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q71U36 | T51 | Sugiyama | TUBA1A TUBA3 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q71U36 | T56 | Sugiyama | TUBA1A TUBA3 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T80 | Sugiyama | TUBA1A TUBA3 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q7KZI7 | T208 | GPS6|SIGNOR|ELM|EPSD|PSP | MARK2 EMK1 | NIKIADFGFSNEFTFGNKLDtFCGsPPYAAPELFQGKKYDG |
| Q7RTN6 | S46 | Sugiyama | STRADA LYK5 STRAD | DLELFGEQPPGDtRRKtNDAssEsIAsFSKQEVMSSFLPEG |
| Q7RTN6 | S47 | Sugiyama | STRADA LYK5 STRAD | LELFGEQPPGDtRRKtNDAssEsIAsFSKQEVMSSFLPEGG |
| Q7RTN6 | S49 | Sugiyama | STRADA LYK5 STRAD | LFGEQPPGDtRRKtNDAssEsIAsFSKQEVMSSFLPEGGCY |
| Q7RTN6 | S52 | Sugiyama | STRADA LYK5 STRAD | EQPPGDtRRKtNDAssEsIAsFSKQEVMSSFLPEGGCYELL |
| Q7RTN6 | T329 | GPS6|SIGNOR|EPSD|PSP | STRADA LYK5 STRAD | ELTMsPSRSVANSGLSDsLTtStPRPSNGDsPSHPYHRTFS |
| Q7RTN6 | T38 | Sugiyama | STRADA LYK5 STRAD | KFIVEGLRDLELFGEQPPGDtRRKtNDAssEsIAsFSKQEV |
| Q7RTN6 | T419 | GPS6|SIGNOR|EPSD|PSP | STRADA LYK5 STRAD | PITNFEGSQSQDHSGIFGLVtNLEELEVDDWEF________ |
| Q7RTN6 | T42 | Sugiyama | STRADA LYK5 STRAD | EGLRDLELFGEQPPGDtRRKtNDAssEsIAsFSKQEVMSSF |
| Q7Z2W4 | T363 | Sugiyama | ZC3HAV1 ZC3HDC2 PRO1677 | NPGstyLASNsTsAPNWKsLtsWtNDQGARRKtVFsPtLPA |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q86V81 | S8 | Sugiyama | ALYREF ALY BEF THOC4 | _____________MADKMDMsLDDIIKLNRSQRGGRGGGRG |
| Q8IWQ3 | T174 | GPS6|SIGNOR|ELM|EPSD|PSP | BRSK2 C11orf7 PEN11B SADA STK29 HUSSY-12 | NIRIADFGMASLQVGDSLLEtSCGSPHYACPEVIRGEKYDG |
| Q8N1G4 | T27 | Sugiyama | LRRC47 KIAA1185 | SESWPELELAERERRRELLLtGPGLEERVRAAGGQLPPRLF |
| Q8NBJ7 | T260 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | SPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMGNtPD |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8TDC3 | T189 | GPS6|SIGNOR|EPSD|PSP | BRSK1 KIAA1811 SAD1 SADB | NIRIADFGMASLQVGDSLLEtSCGSPHYACPEVIKGEKYDG |
| Q96EB6 | S615 | GPS6|SIGNOR|PSP | SIRT1 SIR2L1 | MENPDLKNVGSSTGEKNERtsVAGTVRKCWPNRVAKEQISR |
| Q96EB6 | S669 | GPS6|SIGNOR|PSP | SIRT1 SIR2L1 | RYIFHGAEVYsDsEDDVLSSsSCGSNSDSGTCQsPSLEEPM |
| Q96EB6 | S732 | GPS6|SIGNOR|PSP | SIRT1 SIR2L1 | AGGAGFGtDGDDQEAINEAIsVKQEVTDMNYPsNKs_____ |
| Q96L34 | T214 | GPS6|SIGNOR|ELM|EPSD|PSP | MARK4 KIAA1860 MARKL1 | NIKIADFGFSNEFTLGSKLDtFCGsPPYAAPELFQGKKYDG |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BQE3 | T51 | Sugiyama | TUBA1C TUBA6 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q9BQE3 | T56 | Sugiyama | TUBA1C TUBA6 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T80 | Sugiyama | TUBA1C TUBA6 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9C037 | Y449 | Sugiyama | TRIM4 RNF87 | LIGFPGTPTQQEPALHRVGVyLDRGTGNVSFYSAVDGVHLH |
| Q9H093 | T208 | GPS6|SIGNOR|ELM|EPSD|PSP | NUAK2 OMPHK2 SNARK | NIKIADFGLSNLYHQGKFLQtFCGSPLYASPEIVNGKPYTG |
| Q9H0K1 | T175 | GPS6|SIGNOR|ELM|EPSD|PSP | SIK2 KIAA0781 QIK SNF1LK2 | NIKIADFGFGNFFKSGELLAtWCGSPPYAAPEVFEGQQYEG |
| Q9NRH2 | T173 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SNRK KIAA0096 SNFRK | LVKLTDFGFsNKFQPGKKLTtSCGSLAYSAPEILLGDEYDA |
| Q9NVR5 | S773 | Sugiyama | DNAAF2 C14orf104 KTU | EFIKEKSATCSNEEKDNLNEsVITEEKETDGDHLsSLLNKT |
| Q9P0L2 | S219 | iPTMNet|EPSD | MARK1 KIAA1477 MARK | ADFGFSNEFTVGNKLDtFCGsPPYAAPELFQGKKYDGPEVD |
| Q9P0L2 | T215 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MARK1 KIAA1477 MARK | NIKIADFGFSNEFTVGNKLDtFCGsPPYAAPELFQGKKYDG |
| Q9UNF1 | T90 | Sugiyama | MAGED2 BCG1 | sKtPEAREAPAtQAssttQLtDtQVLAAENKSLAADTKKQN |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2K2 | T221 | SIGNOR|PSP | SIK3 KIAA0999 QSK L19 | NIKIADFGFSNLFTPGQLLKtWCGSPPYAAPELFEGKEYDG |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle, Mitotic | R-HSA-69278 | 0.000004 | 5.413 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 0.000005 | 5.298 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 0.000007 | 5.166 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 0.000020 | 4.705 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 0.000028 | 4.546 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 0.000033 | 4.476 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 0.000054 | 4.269 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 0.000053 | 4.275 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 0.000070 | 4.156 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 0.000080 | 4.100 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 0.000105 | 3.980 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 0.000117 | 3.934 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 0.000106 | 3.975 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 0.000205 | 3.687 | 0 | 0 |
| Kinesins | R-HSA-983189 | 0.000201 | 3.696 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 0.000223 | 3.651 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 0.000254 | 3.596 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 0.000265 | 3.576 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 0.000281 | 3.551 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 0.000316 | 3.500 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 0.000337 | 3.472 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 0.000391 | 3.408 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 0.000391 | 3.407 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 0.000430 | 3.366 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 0.000446 | 3.350 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 0.000484 | 3.315 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 0.000534 | 3.272 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 0.000526 | 3.279 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 0.000596 | 3.225 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 0.000688 | 3.163 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 0.000693 | 3.159 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 0.000787 | 3.104 | 1 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 0.000847 | 3.072 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 0.000828 | 3.082 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 0.001018 | 2.992 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 0.001129 | 2.947 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 0.001197 | 2.922 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 0.001340 | 2.873 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 0.001363 | 2.866 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 0.001430 | 2.845 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 0.001544 | 2.811 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 0.001603 | 2.795 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 0.001623 | 2.790 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 0.001582 | 2.801 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 0.001674 | 2.776 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 0.001970 | 2.706 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 0.002033 | 2.692 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 0.002041 | 2.690 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 0.001980 | 2.703 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 0.001980 | 2.703 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 0.002089 | 2.680 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 0.001932 | 2.714 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 0.002252 | 2.647 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 0.002719 | 2.566 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 0.002880 | 2.541 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 0.002880 | 2.541 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 0.002880 | 2.541 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 0.002880 | 2.541 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 0.002880 | 2.541 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 0.002681 | 2.572 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 0.002681 | 2.572 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 0.002690 | 2.570 | 0 | 0 |
| M Phase | R-HSA-68886 | 0.002596 | 2.586 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 0.002708 | 2.567 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 0.003137 | 2.503 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 0.003157 | 2.501 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 0.003174 | 2.498 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 0.003396 | 2.469 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 0.003388 | 2.470 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 0.003485 | 2.458 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 0.003551 | 2.450 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 0.003658 | 2.437 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 0.003907 | 2.408 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 0.003918 | 2.407 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 0.004387 | 2.358 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 0.004391 | 2.357 | 0 | 0 |
| Protein folding | R-HSA-391251 | 0.004892 | 2.311 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 0.004905 | 2.309 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 0.005042 | 2.297 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 0.005170 | 2.286 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 0.005851 | 2.233 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 0.006276 | 2.202 | 1 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 0.006872 | 2.163 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 0.006881 | 2.162 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 0.006960 | 2.157 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 0.007432 | 2.129 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 0.007451 | 2.128 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 0.007451 | 2.128 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 0.008328 | 2.079 | 1 | 1 |
| Cellular responses to stimuli | R-HSA-8953897 | 0.007768 | 2.110 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 0.008480 | 2.072 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 0.009255 | 2.034 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 0.009257 | 2.034 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 0.008887 | 2.051 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 0.008979 | 2.047 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 0.009255 | 2.034 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 0.008893 | 2.051 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 0.008654 | 2.063 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 0.009430 | 2.025 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 0.009920 | 2.003 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 0.010247 | 1.989 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 0.010972 | 1.960 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 0.011068 | 1.956 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 0.011318 | 1.946 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 0.012355 | 1.908 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 0.011868 | 1.926 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 0.012374 | 1.907 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 0.012938 | 1.888 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 0.013121 | 1.882 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 0.013353 | 1.874 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 0.014716 | 1.832 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 0.015307 | 1.815 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 0.016566 | 1.781 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 0.017440 | 1.758 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 0.017440 | 1.758 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 0.017440 | 1.758 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 0.015904 | 1.799 | 1 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 0.017011 | 1.769 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 0.017642 | 1.753 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 0.019526 | 1.709 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 0.019736 | 1.705 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 0.020854 | 1.681 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 0.022527 | 1.647 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 0.024178 | 1.617 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 0.025330 | 1.596 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 0.025127 | 1.600 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 0.024572 | 1.610 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 0.026776 | 1.572 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 0.026776 | 1.572 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 0.026776 | 1.572 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 0.027299 | 1.564 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 0.027351 | 1.563 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 0.027351 | 1.563 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 0.027351 | 1.563 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 0.027351 | 1.563 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 0.027351 | 1.563 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 0.027351 | 1.563 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 0.027351 | 1.563 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 0.028869 | 1.540 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 0.029016 | 1.537 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 0.028546 | 1.544 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 0.031135 | 1.507 | 1 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 0.031473 | 1.502 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 0.031517 | 1.501 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 0.031517 | 1.501 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 0.031517 | 1.501 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 0.031517 | 1.501 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 0.031517 | 1.501 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 0.031700 | 1.499 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 0.032461 | 1.489 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 0.033752 | 1.472 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 0.033933 | 1.469 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 0.034873 | 1.458 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 0.036216 | 1.441 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 0.036216 | 1.441 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 0.036667 | 1.436 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 0.041529 | 1.382 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 0.041529 | 1.382 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 0.044426 | 1.352 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 0.040612 | 1.391 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 0.043551 | 1.361 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 0.046023 | 1.337 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 0.046023 | 1.337 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 0.048094 | 1.318 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 0.048169 | 1.317 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 0.048169 | 1.317 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 0.048169 | 1.317 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 0.050073 | 1.300 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 0.051083 | 1.292 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 0.051589 | 1.287 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 0.051804 | 1.286 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 0.051804 | 1.286 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 0.054159 | 1.266 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 0.061217 | 1.213 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 0.060308 | 1.220 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 0.055676 | 1.254 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 0.062417 | 1.205 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 0.062310 | 1.205 | 0 | 0 |
| S Phase | R-HSA-69242 | 0.054268 | 1.265 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 0.057663 | 1.239 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 0.056676 | 1.247 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 0.058673 | 1.232 | 1 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 0.054505 | 1.264 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 0.061036 | 1.214 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 0.063509 | 1.197 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 0.066245 | 1.179 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 0.066763 | 1.175 | 1 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 0.067615 | 1.170 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 0.068091 | 1.167 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 0.068091 | 1.167 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 0.068295 | 1.166 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 0.068854 | 1.162 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 0.068854 | 1.162 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 0.070102 | 1.154 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 0.070492 | 1.152 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 0.070492 | 1.152 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 0.081335 | 1.090 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 0.081335 | 1.090 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 0.081335 | 1.090 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 0.081335 | 1.090 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 0.081335 | 1.090 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 0.080184 | 1.096 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 0.076272 | 1.118 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 0.077461 | 1.111 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 0.077461 | 1.111 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 0.080184 | 1.096 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 0.073361 | 1.135 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 0.081335 | 1.090 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 0.081335 | 1.090 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 0.074423 | 1.128 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 0.084628 | 1.072 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 0.084628 | 1.072 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 0.077684 | 1.110 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 0.071336 | 1.147 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 0.080389 | 1.095 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 0.075725 | 1.121 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 0.080213 | 1.096 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 0.082297 | 1.085 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 0.119491 | 0.923 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 0.119491 | 0.923 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 0.119491 | 0.923 | 0 | 0 |
| Defective CD320 causes MMATC | R-HSA-3359485 | 0.119491 | 0.923 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 0.156064 | 0.807 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 0.156064 | 0.807 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 0.156064 | 0.807 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 0.156064 | 0.807 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 0.156064 | 0.807 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 0.156064 | 0.807 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 0.156064 | 0.807 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 0.156064 | 0.807 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 0.156064 | 0.807 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 0.156064 | 0.807 | 0 | 0 |
| Defective SLC12A1 causes Bartter syndrome 1 (BS1) | R-HSA-5619104 | 0.156064 | 0.807 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 0.156064 | 0.807 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 0.156064 | 0.807 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 0.191120 | 0.719 | 0 | 0 |
| Defective HPRT1 disrupts guanine and hypoxanthine salvage | R-HSA-9734281 | 0.191120 | 0.719 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 0.191120 | 0.719 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 0.191120 | 0.719 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 0.092881 | 1.032 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 0.224722 | 0.648 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 0.224722 | 0.648 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 0.224722 | 0.648 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 0.224722 | 0.648 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 0.106111 | 0.974 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 0.106111 | 0.974 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 0.119807 | 0.922 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 0.119807 | 0.922 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 0.119807 | 0.922 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 0.119807 | 0.922 | 0 | 0 |
| IRS activation | R-HSA-74713 | 0.256931 | 0.590 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 0.256931 | 0.590 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 0.133908 | 0.873 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 0.133908 | 0.873 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 0.148357 | 0.829 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 0.148357 | 0.829 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 0.148357 | 0.829 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 0.148357 | 0.829 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 0.148357 | 0.829 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 0.148357 | 0.829 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 0.287802 | 0.541 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 0.287802 | 0.541 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 0.287802 | 0.541 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 0.287802 | 0.541 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 0.287802 | 0.541 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 0.287802 | 0.541 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 0.287802 | 0.541 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 0.287802 | 0.541 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 0.287802 | 0.541 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 0.287802 | 0.541 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 0.091590 | 1.038 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 0.163101 | 0.788 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 0.178090 | 0.749 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 0.178090 | 0.749 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 0.317394 | 0.498 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 0.317394 | 0.498 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 0.317394 | 0.498 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 0.317394 | 0.498 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 0.317394 | 0.498 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 0.117684 | 0.929 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 0.193280 | 0.714 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 0.193280 | 0.714 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 0.092436 | 1.034 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 0.136433 | 0.865 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 0.136433 | 0.865 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 0.208627 | 0.681 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 0.345757 | 0.461 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 0.345757 | 0.461 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 0.345757 | 0.461 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 0.224092 | 0.650 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 0.224092 | 0.650 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 0.156120 | 0.807 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 0.166275 | 0.779 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 0.239639 | 0.620 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 0.372943 | 0.428 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 0.372943 | 0.428 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 0.255234 | 0.593 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 0.187134 | 0.728 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 0.114524 | 0.941 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 0.270848 | 0.567 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 0.270848 | 0.567 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 0.399002 | 0.399 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 0.399002 | 0.399 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 0.165030 | 0.782 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 0.286451 | 0.543 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 0.286451 | 0.543 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 0.286451 | 0.543 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 0.286451 | 0.543 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 0.302017 | 0.520 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 0.423979 | 0.373 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 0.128090 | 0.892 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 0.198458 | 0.702 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 0.317523 | 0.498 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 0.253015 | 0.597 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 0.332947 | 0.478 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 0.111905 | 0.951 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 0.186291 | 0.730 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 0.186291 | 0.730 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 0.141653 | 0.849 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 0.208203 | 0.682 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 0.251873 | 0.599 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 0.251873 | 0.599 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 0.363470 | 0.440 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 0.161056 | 0.793 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 0.161056 | 0.793 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 0.270317 | 0.568 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 0.378535 | 0.422 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 0.288987 | 0.539 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 0.262182 | 0.581 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 0.278177 | 0.556 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 0.253262 | 0.596 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 0.317294 | 0.499 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 0.317294 | 0.499 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 0.244245 | 0.612 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 0.326785 | 0.486 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 0.250544 | 0.601 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 0.184568 | 0.734 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 0.302513 | 0.519 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 0.288845 | 0.539 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 0.296090 | 0.529 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 0.374371 | 0.427 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 0.423973 | 0.373 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 0.355054 | 0.450 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 0.315391 | 0.501 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 0.421666 | 0.375 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 0.326989 | 0.485 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 0.337824 | 0.471 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 0.286451 | 0.543 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 0.393449 | 0.405 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 0.422769 | 0.374 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 0.410104 | 0.387 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 0.117630 | 0.929 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 0.208621 | 0.681 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 0.197806 | 0.704 | 1 | 1 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 0.378863 | 0.422 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 0.401538 | 0.396 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 0.401538 | 0.396 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 0.401538 | 0.396 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 0.363470 | 0.440 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 0.344541 | 0.463 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 0.307827 | 0.512 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 0.131598 | 0.881 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 0.224092 | 0.650 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 0.230619 | 0.637 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 0.423979 | 0.373 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 0.423979 | 0.373 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 0.317523 | 0.498 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 0.122282 | 0.913 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 0.321556 | 0.493 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 0.086219 | 1.064 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 0.390227 | 0.409 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 0.241774 | 0.617 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 0.148357 | 0.829 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 0.148357 | 0.829 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 0.178090 | 0.749 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 0.224092 | 0.650 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 0.112309 | 0.950 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 0.166275 | 0.779 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 0.399002 | 0.399 | 1 | 1 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 0.230619 | 0.637 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 0.317523 | 0.498 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 0.275703 | 0.560 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 0.315835 | 0.501 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 0.205791 | 0.687 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 0.187134 | 0.728 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 0.241774 | 0.617 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 0.315835 | 0.501 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 0.136433 | 0.865 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 0.133482 | 0.875 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 0.144584 | 0.840 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 0.421666 | 0.375 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 0.088774 | 1.052 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 0.092881 | 1.032 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 0.119807 | 0.922 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 0.256931 | 0.590 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 0.256931 | 0.590 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 0.098861 | 1.005 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 0.224092 | 0.650 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 0.372943 | 0.428 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 0.230619 | 0.637 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 0.107391 | 0.969 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 0.250544 | 0.601 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 0.345810 | 0.461 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 0.390227 | 0.409 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 0.401538 | 0.396 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 0.407301 | 0.390 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 0.199659 | 0.700 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 0.219563 | 0.658 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 0.393361 | 0.405 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 0.145296 | 0.838 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 0.224722 | 0.648 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 0.256931 | 0.590 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 0.224092 | 0.650 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 0.399002 | 0.399 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 0.132587 | 0.877 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 0.219563 | 0.658 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 0.423979 | 0.373 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 0.158503 | 0.800 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 0.238621 | 0.622 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 0.408197 | 0.389 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 0.296090 | 0.529 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 0.103351 | 0.986 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 0.258572 | 0.587 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 0.089088 | 1.050 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 0.144756 | 0.839 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 0.120407 | 0.919 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 0.286451 | 0.543 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 0.246411 | 0.608 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 0.408197 | 0.389 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 0.399002 | 0.399 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 0.253015 | 0.597 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 0.307827 | 0.512 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 0.187134 | 0.728 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 0.128090 | 0.892 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 0.131808 | 0.880 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 0.361089 | 0.442 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 0.119491 | 0.923 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 0.156064 | 0.807 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 0.156064 | 0.807 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 0.191120 | 0.719 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 0.256931 | 0.590 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 0.133908 | 0.873 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 0.133908 | 0.873 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 0.287802 | 0.541 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 0.287802 | 0.541 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 0.163101 | 0.788 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 0.141437 | 0.849 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 0.141437 | 0.849 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 0.141437 | 0.849 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 0.423979 | 0.373 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 0.423979 | 0.373 | 0 | 0 |
| Metabolism of serotonin | R-HSA-380612 | 0.423979 | 0.373 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 0.253015 | 0.597 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 0.310062 | 0.509 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 0.321556 | 0.493 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 0.393449 | 0.405 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 0.360298 | 0.443 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 0.111415 | 0.953 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 0.230619 | 0.637 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 0.218527 | 0.660 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 0.182743 | 0.738 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 0.368607 | 0.433 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 0.390227 | 0.409 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 0.325336 | 0.488 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 0.317294 | 0.499 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 0.108700 | 0.964 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 0.276641 | 0.558 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 0.207600 | 0.683 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 0.207539 | 0.683 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 0.207539 | 0.683 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 0.345757 | 0.461 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 0.224092 | 0.650 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 0.128253 | 0.892 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 0.369967 | 0.432 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 0.369967 | 0.432 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 0.224102 | 0.650 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 0.224102 | 0.650 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 0.423979 | 0.373 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 0.393449 | 0.405 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 0.223255 | 0.651 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 0.173260 | 0.761 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 0.086061 | 1.065 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 0.286729 | 0.543 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 0.193280 | 0.714 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 0.318915 | 0.496 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 0.172179 | 0.764 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 0.342799 | 0.465 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 0.303883 | 0.517 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 0.184423 | 0.734 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 0.148357 | 0.829 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 0.287802 | 0.541 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 0.345757 | 0.461 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 0.399002 | 0.399 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 0.399002 | 0.399 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 0.423979 | 0.373 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 0.423979 | 0.373 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 0.298581 | 0.525 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 0.184423 | 0.734 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 0.184423 | 0.734 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 0.128090 | 0.892 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 0.108709 | 0.964 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 0.352979 | 0.452 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 0.378863 | 0.422 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 0.355333 | 0.449 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 0.244245 | 0.612 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 0.251873 | 0.599 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 0.108700 | 0.964 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 0.224092 | 0.650 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 0.363470 | 0.440 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 0.288987 | 0.539 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 0.204110 | 0.690 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 0.086219 | 1.064 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 0.287124 | 0.542 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 0.186251 | 0.730 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 0.172621 | 0.763 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 0.119491 | 0.923 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 0.224722 | 0.648 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 0.178090 | 0.749 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 0.345757 | 0.461 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 0.345757 | 0.461 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 0.372943 | 0.428 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 0.399002 | 0.399 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 0.399002 | 0.399 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 0.126429 | 0.898 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 0.190114 | 0.721 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 0.401538 | 0.396 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 0.351995 | 0.453 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 0.287375 | 0.542 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 0.246899 | 0.607 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 0.279994 | 0.553 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 0.357683 | 0.447 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 0.092772 | 1.033 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 0.109613 | 0.960 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 0.275703 | 0.560 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 0.165030 | 0.782 | 1 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 0.378535 | 0.422 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 0.333052 | 0.477 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 0.107899 | 0.967 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 0.205791 | 0.687 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 0.096848 | 1.014 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 0.282201 | 0.549 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 0.378863 | 0.422 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 0.378863 | 0.422 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 0.412789 | 0.384 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 0.119807 | 0.922 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 0.317394 | 0.498 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 0.270848 | 0.567 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 0.423979 | 0.373 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 0.264329 | 0.578 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 0.275703 | 0.560 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 0.408197 | 0.389 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 0.340186 | 0.468 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 0.399839 | 0.398 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 0.333052 | 0.477 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 0.401538 | 0.396 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 0.148357 | 0.829 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 0.230619 | 0.637 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 0.198458 | 0.702 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 0.229728 | 0.639 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 0.224722 | 0.648 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 0.256931 | 0.590 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 0.287802 | 0.541 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 0.193280 | 0.714 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 0.345757 | 0.461 | 0 | 0 |
| RSK activation | R-HSA-444257 | 0.372943 | 0.428 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 0.399002 | 0.399 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 0.230619 | 0.637 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 0.310062 | 0.509 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 0.362506 | 0.441 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 0.360298 | 0.443 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 0.329275 | 0.482 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 0.192099 | 0.716 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 0.270848 | 0.567 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 0.302017 | 0.520 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 0.423979 | 0.373 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 0.086219 | 1.064 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 0.407301 | 0.390 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 0.363047 | 0.440 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 0.148357 | 0.829 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 0.126934 | 0.896 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 0.086219 | 1.064 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 0.142275 | 0.847 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 0.106111 | 0.974 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 0.399002 | 0.399 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 0.238621 | 0.622 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 0.326785 | 0.486 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 0.367456 | 0.435 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 0.345810 | 0.461 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 0.092881 | 1.032 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 0.256931 | 0.590 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 0.287802 | 0.541 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 0.287802 | 0.541 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 0.099997 | 1.000 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 0.317394 | 0.498 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 0.317394 | 0.498 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 0.193280 | 0.714 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 0.126934 | 0.896 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 0.239639 | 0.620 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 0.399002 | 0.399 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 0.399002 | 0.399 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 0.138981 | 0.857 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 0.317394 | 0.498 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 0.092436 | 1.034 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 0.286451 | 0.543 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 0.224752 | 0.648 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 0.224752 | 0.648 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 0.378863 | 0.422 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 0.223486 | 0.651 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 0.419483 | 0.377 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 0.286451 | 0.543 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 0.275703 | 0.560 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 0.288987 | 0.539 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 0.401538 | 0.396 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 0.108700 | 0.964 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 0.234076 | 0.631 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 0.275703 | 0.560 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 0.364855 | 0.438 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 0.345757 | 0.461 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 0.255234 | 0.593 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 0.310062 | 0.509 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 0.099997 | 1.000 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 0.399002 | 0.399 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 0.124332 | 0.905 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 0.270848 | 0.567 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 0.423979 | 0.373 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 0.372943 | 0.428 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 0.399002 | 0.399 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 0.317523 | 0.498 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 0.298581 | 0.525 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 0.108700 | 0.964 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 0.372943 | 0.428 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 0.275703 | 0.560 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 0.401072 | 0.397 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 0.344095 | 0.463 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 0.127796 | 0.893 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 0.332947 | 0.478 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 0.348269 | 0.458 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 0.219024 | 0.660 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 0.208627 | 0.681 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 0.260284 | 0.585 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 0.270848 | 0.567 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 0.422769 | 0.374 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 0.427604 | 0.369 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 0.427604 | 0.369 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 0.431034 | 0.365 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 0.431034 | 0.365 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 0.431034 | 0.365 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 0.432777 | 0.364 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 0.434835 | 0.362 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 0.435082 | 0.361 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 0.435082 | 0.361 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 0.437045 | 0.359 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 0.437153 | 0.359 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 0.437153 | 0.359 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 0.439108 | 0.357 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 0.446110 | 0.351 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 0.447919 | 0.349 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 0.447919 | 0.349 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 0.447919 | 0.349 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 0.447919 | 0.349 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 0.447919 | 0.349 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 0.447919 | 0.349 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 0.447919 | 0.349 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 0.447919 | 0.349 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 0.449642 | 0.347 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 0.449642 | 0.347 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 0.451340 | 0.345 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 0.451340 | 0.345 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 0.451340 | 0.345 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 0.451340 | 0.345 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 0.456452 | 0.341 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 0.457052 | 0.340 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 0.457052 | 0.340 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 0.457052 | 0.340 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 0.458874 | 0.338 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 0.459178 | 0.338 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 0.459178 | 0.338 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 0.463178 | 0.334 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 0.465321 | 0.332 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 0.467435 | 0.330 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 0.467902 | 0.330 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 0.467902 | 0.330 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 0.470595 | 0.327 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 0.470866 | 0.327 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 0.470866 | 0.327 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 0.470866 | 0.327 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 0.478654 | 0.320 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 0.479089 | 0.320 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 0.480953 | 0.318 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 0.483521 | 0.316 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 0.486678 | 0.313 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 0.488077 | 0.312 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 0.489303 | 0.310 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 0.490359 | 0.309 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 0.492637 | 0.307 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 0.492637 | 0.307 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 0.492637 | 0.307 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 0.492637 | 0.307 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 0.492637 | 0.307 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 0.492860 | 0.307 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 0.492860 | 0.307 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 0.492860 | 0.307 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 0.492860 | 0.307 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 0.492860 | 0.307 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 0.492860 | 0.307 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 0.492860 | 0.307 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 0.492860 | 0.307 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 0.492860 | 0.307 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 0.492860 | 0.307 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 0.492860 | 0.307 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 0.492860 | 0.307 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 0.500156 | 0.301 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 0.504161 | 0.297 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 0.505960 | 0.296 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 0.505960 | 0.296 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 0.509873 | 0.293 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 0.510274 | 0.292 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 0.510274 | 0.292 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 0.513942 | 0.289 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 0.513942 | 0.289 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 0.513942 | 0.289 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 0.513942 | 0.289 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 0.513942 | 0.289 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 0.513942 | 0.289 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 0.513942 | 0.289 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 0.513942 | 0.289 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 0.513942 | 0.289 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 0.513942 | 0.289 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 0.513942 | 0.289 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 0.519054 | 0.285 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 0.519054 | 0.285 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 0.519054 | 0.285 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 0.519054 | 0.285 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 0.519054 | 0.285 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 0.520589 | 0.284 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 0.522945 | 0.282 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 0.529056 | 0.276 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 0.530515 | 0.275 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 0.530784 | 0.275 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 0.531065 | 0.275 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 0.531914 | 0.274 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 0.531914 | 0.274 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 0.534148 | 0.272 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 0.534148 | 0.272 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 0.534148 | 0.272 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 0.534148 | 0.272 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 0.534148 | 0.272 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 0.534148 | 0.272 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 0.534148 | 0.272 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 0.540856 | 0.267 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 0.540856 | 0.267 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 0.544538 | 0.264 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 0.547696 | 0.261 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 0.547696 | 0.261 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 0.550803 | 0.259 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 0.553515 | 0.257 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 0.553515 | 0.257 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 0.553515 | 0.257 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 0.553515 | 0.257 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 0.553515 | 0.257 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 0.553515 | 0.257 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 0.553515 | 0.257 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 0.553515 | 0.257 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 0.553515 | 0.257 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 0.553515 | 0.257 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 0.553515 | 0.257 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 0.553515 | 0.257 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 0.553515 | 0.257 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 0.553515 | 0.257 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 0.553515 | 0.257 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 0.553515 | 0.257 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 0.553515 | 0.257 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 0.553521 | 0.257 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 0.554864 | 0.256 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 0.556080 | 0.255 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 0.556922 | 0.254 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 0.556922 | 0.254 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 0.556922 | 0.254 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 0.556922 | 0.254 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 0.556922 | 0.254 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 0.556922 | 0.254 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 0.560912 | 0.251 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 0.569064 | 0.245 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 0.569699 | 0.244 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 0.572079 | 0.243 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 0.572079 | 0.243 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 0.572079 | 0.243 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 0.572079 | 0.243 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 0.572079 | 0.243 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 0.572079 | 0.243 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 0.572079 | 0.243 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 0.572079 | 0.243 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 0.572079 | 0.243 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 0.572838 | 0.242 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 0.575811 | 0.240 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 0.579864 | 0.237 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 0.579864 | 0.237 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 0.580964 | 0.236 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 0.580964 | 0.236 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 0.580964 | 0.236 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 0.580964 | 0.236 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 0.589872 | 0.229 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 0.589872 | 0.229 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 0.589872 | 0.229 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 0.589872 | 0.229 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 0.589872 | 0.229 | 0 | 0 |
| Vitamin B6 activation to pyridoxal phosphate | R-HSA-964975 | 0.589872 | 0.229 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 0.589872 | 0.229 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 0.589872 | 0.229 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 0.590340 | 0.229 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 0.590340 | 0.229 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 0.592621 | 0.227 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 0.592621 | 0.227 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 0.597176 | 0.224 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 0.598566 | 0.223 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 0.600322 | 0.222 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 0.604033 | 0.219 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 0.604033 | 0.219 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 0.604033 | 0.219 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 0.604033 | 0.219 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 0.604592 | 0.219 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 0.605102 | 0.218 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 0.606925 | 0.217 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 0.606925 | 0.217 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 0.606925 | 0.217 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 0.606925 | 0.217 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 0.606925 | 0.217 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 0.606925 | 0.217 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 0.606925 | 0.217 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 0.606925 | 0.217 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 0.606925 | 0.217 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 0.606925 | 0.217 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 0.615203 | 0.211 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 0.615203 | 0.211 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 0.615203 | 0.211 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 0.615203 | 0.211 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 0.615203 | 0.211 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 0.615203 | 0.211 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 0.616714 | 0.210 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 0.618145 | 0.209 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 0.623271 | 0.205 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 0.623271 | 0.205 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 0.623271 | 0.205 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 0.623271 | 0.205 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 0.623271 | 0.205 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 0.623271 | 0.205 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 0.623271 | 0.205 | 1 | 1 |
| Mismatch Repair | R-HSA-5358508 | 0.623271 | 0.205 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 0.623271 | 0.205 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 0.636812 | 0.196 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 0.636812 | 0.196 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 0.638938 | 0.195 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 0.638938 | 0.195 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 0.638938 | 0.195 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 0.638938 | 0.195 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 0.638938 | 0.195 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 0.638938 | 0.195 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 0.638938 | 0.195 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 0.638938 | 0.195 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 0.643278 | 0.192 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 0.645643 | 0.190 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 0.647255 | 0.189 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 0.650616 | 0.187 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 0.652161 | 0.186 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 0.653955 | 0.184 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 0.653955 | 0.184 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 0.653955 | 0.184 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 0.653955 | 0.184 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 0.653955 | 0.184 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 0.653955 | 0.184 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 0.657458 | 0.182 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 0.657458 | 0.182 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 0.659609 | 0.181 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 0.665064 | 0.177 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 0.667424 | 0.176 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 0.667424 | 0.176 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 0.667424 | 0.176 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 0.668347 | 0.175 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 0.668347 | 0.175 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 0.668347 | 0.175 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 0.668347 | 0.175 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 0.668347 | 0.175 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 0.668347 | 0.175 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 0.668347 | 0.175 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 0.668347 | 0.175 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 0.672381 | 0.172 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 0.677154 | 0.169 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 0.677154 | 0.169 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 0.682142 | 0.166 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 0.682142 | 0.166 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 0.682142 | 0.166 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 0.682142 | 0.166 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 0.682142 | 0.166 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 0.682142 | 0.166 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 0.685777 | 0.164 | 1 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 0.686651 | 0.163 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 0.691350 | 0.160 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 0.691350 | 0.160 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 0.695364 | 0.158 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 0.695364 | 0.158 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 0.695364 | 0.158 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 0.695364 | 0.158 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 0.695364 | 0.158 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 0.698826 | 0.156 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 0.698928 | 0.156 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 0.704957 | 0.152 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 0.705359 | 0.152 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 0.705642 | 0.151 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 0.707718 | 0.150 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 0.707718 | 0.150 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 0.707718 | 0.150 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 0.708037 | 0.150 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 0.708037 | 0.150 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 0.708037 | 0.150 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 0.708037 | 0.150 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 0.708037 | 0.150 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 0.708037 | 0.150 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 0.708037 | 0.150 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 0.708037 | 0.150 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 0.712730 | 0.147 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 0.713770 | 0.146 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 0.713770 | 0.146 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 0.716420 | 0.145 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 0.719181 | 0.143 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 0.720183 | 0.143 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 0.720183 | 0.143 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 0.720812 | 0.142 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 0.722362 | 0.141 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 0.724791 | 0.140 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 0.727827 | 0.138 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 0.727827 | 0.138 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 0.730689 | 0.136 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 0.730736 | 0.136 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 0.730736 | 0.136 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 0.730736 | 0.136 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 0.730736 | 0.136 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 0.731825 | 0.136 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 0.731825 | 0.136 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 0.731825 | 0.136 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 0.731825 | 0.136 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 0.731825 | 0.136 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 0.731825 | 0.136 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 0.731825 | 0.136 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 0.731825 | 0.136 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 0.731825 | 0.136 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 0.731825 | 0.136 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 0.735768 | 0.133 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 0.737632 | 0.132 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 0.742983 | 0.129 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 0.742983 | 0.129 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 0.742983 | 0.129 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 0.742983 | 0.129 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 0.742983 | 0.129 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 0.742983 | 0.129 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 0.742983 | 0.129 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 0.742983 | 0.129 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 0.742983 | 0.129 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 0.742983 | 0.129 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 0.746839 | 0.127 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 0.748403 | 0.126 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 0.753677 | 0.123 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 0.753677 | 0.123 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 0.753677 | 0.123 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 0.753677 | 0.123 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 0.753677 | 0.123 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 0.753677 | 0.123 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 0.753677 | 0.123 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 0.753677 | 0.123 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 0.754577 | 0.122 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 0.754577 | 0.122 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 0.754577 | 0.122 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 0.756758 | 0.121 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 0.759708 | 0.119 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 0.759835 | 0.119 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 0.760219 | 0.119 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 0.762109 | 0.118 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 0.762109 | 0.118 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 0.763927 | 0.117 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 0.763927 | 0.117 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 0.763927 | 0.117 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 0.763927 | 0.117 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 0.763927 | 0.117 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 0.763927 | 0.117 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 0.763927 | 0.117 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 0.766979 | 0.115 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 0.769441 | 0.114 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 0.773103 | 0.112 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 0.773103 | 0.112 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 0.773752 | 0.111 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 0.773752 | 0.111 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 0.773752 | 0.111 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 0.774503 | 0.111 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 0.776475 | 0.110 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 0.776575 | 0.110 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 0.776575 | 0.110 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 0.778311 | 0.109 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 0.781133 | 0.107 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 0.783167 | 0.106 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 0.783167 | 0.106 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 0.783167 | 0.106 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 0.783167 | 0.106 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 0.783258 | 0.106 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 0.783935 | 0.106 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 0.790265 | 0.102 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 0.790265 | 0.102 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 0.790265 | 0.102 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 0.790530 | 0.102 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 0.792192 | 0.101 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 0.792192 | 0.101 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 0.792192 | 0.101 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 0.792192 | 0.101 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 0.792192 | 0.101 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 0.792192 | 0.101 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 0.792192 | 0.101 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 0.792192 | 0.101 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 0.792192 | 0.101 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 0.796829 | 0.099 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 0.796829 | 0.099 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 0.800841 | 0.096 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 0.800841 | 0.096 | 0 | 0 |
| Disease | R-HSA-1643685 | 0.803447 | 0.095 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 0.809131 | 0.092 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 0.809131 | 0.092 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 0.809131 | 0.092 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 0.809131 | 0.092 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 0.809413 | 0.092 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 0.809413 | 0.092 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 0.809413 | 0.092 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 0.810395 | 0.091 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 0.812023 | 0.090 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 0.815441 | 0.089 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 0.815441 | 0.089 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 0.817077 | 0.088 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 0.817077 | 0.088 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 0.817077 | 0.088 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 0.817077 | 0.088 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 0.817077 | 0.088 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 0.817095 | 0.088 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 0.821744 | 0.085 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 0.824692 | 0.084 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 0.824692 | 0.084 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 0.824692 | 0.084 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 0.824692 | 0.084 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 0.824692 | 0.084 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 0.824692 | 0.084 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 0.824692 | 0.084 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 0.824692 | 0.084 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 0.824692 | 0.084 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 0.824692 | 0.084 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 0.824692 | 0.084 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 0.825738 | 0.083 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 0.826987 | 0.083 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 0.829924 | 0.081 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 0.831990 | 0.080 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 0.831990 | 0.080 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 0.831990 | 0.080 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 0.831990 | 0.080 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 0.831990 | 0.080 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 0.831990 | 0.080 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 0.831990 | 0.080 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 0.831990 | 0.080 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 0.831990 | 0.080 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 0.832108 | 0.080 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 0.832270 | 0.080 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 0.832514 | 0.080 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 0.832514 | 0.080 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 0.836237 | 0.078 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 0.836384 | 0.078 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 0.837880 | 0.077 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 0.838986 | 0.076 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 0.838986 | 0.076 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 0.838986 | 0.076 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 0.838986 | 0.076 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 0.838986 | 0.076 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 0.838986 | 0.076 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 0.838986 | 0.076 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 0.839267 | 0.076 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 0.842757 | 0.074 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 0.843090 | 0.074 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 0.845690 | 0.073 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 0.845690 | 0.073 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 0.845690 | 0.073 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 0.845690 | 0.073 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 0.848148 | 0.072 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 0.848148 | 0.072 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 0.849437 | 0.071 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 0.852115 | 0.070 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 0.852115 | 0.070 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 0.852115 | 0.070 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 0.852115 | 0.070 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 0.853627 | 0.069 | 0 | 0 |
| Translation | R-HSA-72766 | 0.858246 | 0.066 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 0.858274 | 0.066 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 0.858274 | 0.066 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 0.858274 | 0.066 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 0.858274 | 0.066 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 0.862445 | 0.064 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 0.862445 | 0.064 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 0.864142 | 0.063 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 0.864176 | 0.063 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 0.864176 | 0.063 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 0.864176 | 0.063 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 0.864176 | 0.063 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 0.864176 | 0.063 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 0.864176 | 0.063 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 0.864176 | 0.063 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 0.864176 | 0.063 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 0.864176 | 0.063 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 0.865591 | 0.063 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 0.866930 | 0.062 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 0.866930 | 0.062 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 0.869733 | 0.061 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 0.869833 | 0.061 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 0.869833 | 0.061 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 0.869833 | 0.061 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 0.869833 | 0.061 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 0.872927 | 0.059 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 0.874802 | 0.058 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 0.875254 | 0.058 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 0.875254 | 0.058 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 0.875254 | 0.058 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 0.876687 | 0.057 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 0.879590 | 0.056 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 0.879590 | 0.056 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 0.880450 | 0.055 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 0.880450 | 0.055 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 0.880450 | 0.055 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 0.880450 | 0.055 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 0.880450 | 0.055 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 0.882817 | 0.054 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 0.883557 | 0.054 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 0.885430 | 0.053 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 0.885430 | 0.053 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 0.885430 | 0.053 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 0.890203 | 0.051 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 0.890203 | 0.051 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 0.893417 | 0.049 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 0.894743 | 0.048 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 0.894777 | 0.048 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 0.894777 | 0.048 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 0.894777 | 0.048 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 0.894777 | 0.048 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 0.894777 | 0.048 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 0.894777 | 0.048 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 0.897240 | 0.047 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 0.898244 | 0.047 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 0.898244 | 0.047 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 0.899161 | 0.046 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 0.899161 | 0.046 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 0.899161 | 0.046 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 0.899766 | 0.046 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 0.899766 | 0.046 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 0.899766 | 0.046 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 0.902397 | 0.045 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 0.903362 | 0.044 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 0.903362 | 0.044 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 0.907389 | 0.042 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 0.907389 | 0.042 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 0.908868 | 0.041 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 0.911248 | 0.040 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 0.912359 | 0.040 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 0.914947 | 0.039 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 0.917710 | 0.037 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 0.921889 | 0.035 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 0.921889 | 0.035 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 0.921889 | 0.035 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 0.925144 | 0.034 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 0.925144 | 0.034 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 0.925144 | 0.034 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 0.928265 | 0.032 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 0.930207 | 0.031 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 0.932587 | 0.030 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 0.934890 | 0.029 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 0.939500 | 0.027 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 0.941359 | 0.026 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 0.942022 | 0.026 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 0.942022 | 0.026 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 0.944440 | 0.025 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 0.944440 | 0.025 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 0.944440 | 0.025 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 0.944440 | 0.025 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 0.946757 | 0.024 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 0.946757 | 0.024 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 0.946757 | 0.024 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 0.948977 | 0.023 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 0.948977 | 0.023 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 0.951105 | 0.022 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 0.953145 | 0.021 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 0.956734 | 0.019 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 0.958545 | 0.018 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 0.958767 | 0.018 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 0.958767 | 0.018 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 0.958767 | 0.018 | 0 | 0 |
| Immune System | R-HSA-168256 | 0.958851 | 0.018 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 0.960487 | 0.018 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 0.960487 | 0.018 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 0.960643 | 0.017 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 0.961621 | 0.017 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 0.963435 | 0.016 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 0.963571 | 0.016 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 0.963716 | 0.016 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 0.965230 | 0.015 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 0.965230 | 0.015 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 0.965825 | 0.015 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 0.966681 | 0.015 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 0.966681 | 0.015 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 0.969404 | 0.013 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 0.970681 | 0.013 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 0.970681 | 0.013 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 0.971430 | 0.013 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 0.971430 | 0.013 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 0.973077 | 0.012 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 0.973198 | 0.012 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 0.974201 | 0.011 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 0.974201 | 0.011 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 0.974201 | 0.011 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 0.975443 | 0.011 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 0.976310 | 0.010 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 0.978441 | 0.009 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 0.978987 | 0.009 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 0.981734 | 0.008 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 0.982425 | 0.008 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 0.985183 | 0.006 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 0.985542 | 0.006 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 0.986493 | 0.006 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 0.986964 | 0.006 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 0.986964 | 0.006 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 0.987509 | 0.005 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 0.989470 | 0.005 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 0.990332 | 0.004 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 0.991123 | 0.004 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 0.992517 | 0.003 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 0.994107 | 0.003 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 0.994325 | 0.002 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 0.995120 | 0.002 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 0.995519 | 0.002 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 0.996224 | 0.002 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 0.996224 | 0.002 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 0.996354 | 0.002 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 0.996660 | 0.001 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 0.997318 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 0.997538 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 0.998175 | 0.001 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 0.998323 | 0.001 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 0.998350 | 0.001 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 0.998408 | 0.001 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 0.998439 | 0.001 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 0.998527 | 0.001 | 1 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 0.998716 | 0.001 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 0.999040 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 0.999247 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 0.999534 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 0.999599 | 0.000 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 0.999685 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 0.999698 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 0.999723 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 0.999723 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 0.999734 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 0.999777 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 0.999796 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 0.999854 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 0.999885 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 0.999936 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 0.999962 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 0.999981 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 0.999987 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 0.999989 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 0.999994 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 0.999995 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 0.999997 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 0.999999 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000 | -0.000 | 1 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Apoptotic execution phase | R-HSA-75153 | 1.332268e-15 | 14.875 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.003242e-10 | 9.698 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 2.056652e-10 | 9.687 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 7.438233e-10 | 9.129 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.019616e-09 | 8.992 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.614753e-09 | 8.792 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 6.745289e-09 | 8.171 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.752952e-08 | 7.323 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 7.053785e-08 | 7.152 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 9.521786e-08 | 7.021 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.511968e-07 | 6.346 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 4.625031e-07 | 6.335 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 4.706484e-07 | 6.327 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.849636e-07 | 6.233 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 6.229042e-07 | 6.206 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.025678e-06 | 5.989 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.418634e-06 | 5.848 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.403141e-06 | 5.853 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.478659e-06 | 5.830 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.878161e-06 | 5.726 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.322018e-06 | 5.634 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.322018e-06 | 5.634 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.322018e-06 | 5.634 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.322018e-06 | 5.634 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.124299e-06 | 5.673 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.433017e-06 | 5.614 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 3.362601e-06 | 5.473 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.713941e-06 | 5.327 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 5.532755e-06 | 5.257 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 5.580164e-06 | 5.253 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 6.422036e-06 | 5.192 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 6.671867e-06 | 5.176 | 1 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.247915e-06 | 5.140 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.163667e-05 | 4.934 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.269013e-05 | 4.897 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.319652e-05 | 4.880 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.572458e-05 | 4.803 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.644026e-05 | 4.784 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.870950e-05 | 4.728 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.925832e-05 | 4.715 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.936260e-05 | 4.713 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.101994e-05 | 4.677 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.320363e-05 | 4.634 | 1 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.617192e-05 | 4.582 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.740520e-05 | 4.562 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.757862e-05 | 4.559 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.757862e-05 | 4.559 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 2.977526e-05 | 4.526 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 3.172114e-05 | 4.499 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.254592e-05 | 4.488 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 3.298925e-05 | 4.482 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 3.298925e-05 | 4.482 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.192855e-05 | 4.496 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.678473e-05 | 4.434 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 3.710577e-05 | 4.431 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 4.146650e-05 | 4.382 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.980609e-05 | 4.400 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 4.354215e-05 | 4.361 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 4.289242e-05 | 4.368 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 4.354215e-05 | 4.361 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.434243e-05 | 4.353 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.844059e-05 | 4.315 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 5.313612e-05 | 4.275 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 5.194515e-05 | 4.284 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 6.329583e-05 | 4.199 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 7.079643e-05 | 4.150 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 7.298322e-05 | 4.137 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 8.665780e-05 | 4.062 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 8.816607e-05 | 4.055 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.119198e-04 | 3.951 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.066621e-04 | 3.972 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.066621e-04 | 3.972 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.235875e-04 | 3.908 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.253749e-04 | 3.902 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.283508e-04 | 3.892 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.480310e-04 | 3.830 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.480310e-04 | 3.830 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.498967e-04 | 3.824 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.517167e-04 | 3.819 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.803794e-04 | 3.744 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.715302e-04 | 3.766 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.743792e-04 | 3.759 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.905504e-04 | 3.720 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.348496e-04 | 3.629 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.370942e-04 | 3.625 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.636105e-04 | 3.579 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.636105e-04 | 3.579 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.584205e-04 | 3.588 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.636588e-04 | 3.579 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.636768e-04 | 3.579 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.636768e-04 | 3.579 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.686112e-04 | 3.571 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.695394e-04 | 3.569 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.156793e-04 | 3.501 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.745066e-04 | 3.427 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.890832e-04 | 3.410 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.989357e-04 | 3.399 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.989357e-04 | 3.399 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 4.279729e-04 | 3.369 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.499051e-04 | 3.347 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.817729e-04 | 3.317 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.888592e-04 | 3.311 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 5.571913e-04 | 3.254 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.574941e-04 | 3.254 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 5.682774e-04 | 3.245 | 1 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 5.767176e-04 | 3.239 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 5.802399e-04 | 3.236 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 6.081085e-04 | 3.216 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 6.485344e-04 | 3.188 | 1 | 1 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 6.937279e-04 | 3.159 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 6.409710e-04 | 3.193 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 7.598911e-04 | 3.119 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 8.713474e-04 | 3.060 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 9.586077e-04 | 3.018 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.027701e-03 | 2.988 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.027701e-03 | 2.988 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.042955e-03 | 2.982 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.072965e-03 | 2.969 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.025638e-03 | 2.989 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.033615e-03 | 2.986 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.118955e-03 | 2.951 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.123091e-03 | 2.950 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.157109e-03 | 2.937 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.160826e-03 | 2.935 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.186823e-03 | 2.926 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.226375e-03 | 2.911 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.364627e-03 | 2.865 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.364627e-03 | 2.865 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.408577e-03 | 2.851 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.740189e-03 | 2.759 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.740189e-03 | 2.759 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.744149e-03 | 2.758 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.782201e-03 | 2.749 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.782201e-03 | 2.749 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 1.826906e-03 | 2.738 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 1.826906e-03 | 2.738 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.826906e-03 | 2.738 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.908296e-03 | 2.719 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.939222e-03 | 2.712 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.025049e-03 | 2.694 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.222413e-03 | 2.653 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.292733e-03 | 2.640 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.365335e-03 | 2.626 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.586900e-03 | 2.587 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.392769e-03 | 2.621 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.586900e-03 | 2.587 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.818220e-03 | 2.550 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.901456e-03 | 2.537 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.909232e-03 | 2.536 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.909232e-03 | 2.536 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.909232e-03 | 2.536 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 2.929004e-03 | 2.533 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 3.139739e-03 | 2.503 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.274740e-03 | 2.485 | 1 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.325848e-03 | 2.478 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.325848e-03 | 2.478 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.353267e-03 | 2.475 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 3.367997e-03 | 2.473 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.433376e-03 | 2.464 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 4.086905e-03 | 2.389 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.794803e-03 | 2.421 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.794803e-03 | 2.421 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.933999e-03 | 2.405 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.013605e-03 | 2.396 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.172113e-03 | 2.380 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 4.261722e-03 | 2.370 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 4.620502e-03 | 2.335 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.644805e-03 | 2.333 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.811267e-03 | 2.318 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.861657e-03 | 2.313 | 1 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.877369e-03 | 2.312 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 4.877369e-03 | 2.312 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 4.911674e-03 | 2.309 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.002352e-03 | 2.301 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.162590e-03 | 2.287 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 5.214071e-03 | 2.283 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 6.232689e-03 | 2.205 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 5.771876e-03 | 2.239 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 5.450311e-03 | 2.264 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 5.925447e-03 | 2.227 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 5.896739e-03 | 2.229 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.232689e-03 | 2.205 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 5.532789e-03 | 2.257 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 5.653553e-03 | 2.248 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 5.496493e-03 | 2.260 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 5.397588e-03 | 2.268 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 6.171188e-03 | 2.210 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 5.516976e-03 | 2.258 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 6.232689e-03 | 2.205 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.296070e-03 | 2.201 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 6.421686e-03 | 2.192 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 6.664894e-03 | 2.176 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 6.664894e-03 | 2.176 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 6.713353e-03 | 2.173 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 6.713353e-03 | 2.173 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 6.904205e-03 | 2.161 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 7.145293e-03 | 2.146 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 7.145293e-03 | 2.146 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 7.145293e-03 | 2.146 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 7.369299e-03 | 2.133 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 7.698273e-03 | 2.114 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 7.836118e-03 | 2.106 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 7.836118e-03 | 2.106 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 8.071489e-03 | 2.093 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 8.071489e-03 | 2.093 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 8.509603e-03 | 2.070 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.509603e-03 | 2.070 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 8.509603e-03 | 2.070 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.112526e-02 | 1.954 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.112526e-02 | 1.954 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.112526e-02 | 1.954 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.112526e-02 | 1.954 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.112526e-02 | 1.954 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.112526e-02 | 1.954 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.112526e-02 | 1.954 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.112526e-02 | 1.954 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.112526e-02 | 1.954 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.112526e-02 | 1.954 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.112526e-02 | 1.954 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.047396e-02 | 1.980 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 9.874285e-03 | 2.005 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.032310e-02 | 1.986 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 9.621986e-03 | 2.017 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.063407e-02 | 1.973 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 9.895494e-03 | 2.005 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.048362e-02 | 1.979 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.047367e-02 | 1.980 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 9.275863e-03 | 2.033 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.005995e-02 | 1.997 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.124326e-02 | 1.949 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.124326e-02 | 1.949 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.137949e-02 | 1.944 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.160182e-02 | 1.935 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.172482e-02 | 1.931 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.174576e-02 | 1.930 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.217207e-02 | 1.915 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.229423e-02 | 1.910 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.230266e-02 | 1.910 | 1 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.234039e-02 | 1.909 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.234858e-02 | 1.908 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.267775e-02 | 1.897 | 0 | 0 |
| Translation | R-HSA-72766 | 1.298325e-02 | 1.887 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.317327e-02 | 1.880 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.358843e-02 | 1.867 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.443527e-02 | 1.841 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.443527e-02 | 1.841 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.461636e-02 | 1.835 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.694148e-02 | 1.771 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.843808e-02 | 1.734 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.612978e-02 | 1.792 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.834968e-02 | 1.736 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.575631e-02 | 1.803 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.797299e-02 | 1.745 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.509576e-02 | 1.821 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.509576e-02 | 1.821 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.802420e-02 | 1.744 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.802420e-02 | 1.744 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.638532e-02 | 1.786 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.519013e-02 | 1.818 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.509576e-02 | 1.821 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.488548e-02 | 1.827 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.488390e-02 | 1.827 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.785514e-02 | 1.748 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.604122e-02 | 1.795 | 1 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.557271e-02 | 1.808 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.843808e-02 | 1.734 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 1.843808e-02 | 1.734 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.818013e-02 | 1.740 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.896541e-02 | 1.722 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.899468e-02 | 1.721 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.902749e-02 | 1.721 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.904422e-02 | 1.720 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.936494e-02 | 1.713 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.936494e-02 | 1.713 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.946156e-02 | 1.711 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.956971e-02 | 1.708 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.956971e-02 | 1.708 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.987789e-02 | 1.702 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.002707e-02 | 1.698 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 2.012613e-02 | 1.696 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 2.026747e-02 | 1.693 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.076097e-02 | 1.683 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.120305e-02 | 1.674 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.120305e-02 | 1.674 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.169511e-02 | 1.664 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.203142e-02 | 1.657 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.203142e-02 | 1.657 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.207734e-02 | 1.656 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.222551e-02 | 1.653 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.259758e-02 | 1.646 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.287096e-02 | 1.641 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.287096e-02 | 1.641 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 2.293253e-02 | 1.640 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 2.376001e-02 | 1.624 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 2.377784e-02 | 1.624 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 2.377784e-02 | 1.624 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 2.377784e-02 | 1.624 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.474100e-02 | 1.607 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.478721e-02 | 1.606 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.498061e-02 | 1.602 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.566877e-02 | 1.591 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.599992e-02 | 1.585 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.599992e-02 | 1.585 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.599992e-02 | 1.585 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.599992e-02 | 1.585 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 2.631369e-02 | 1.580 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.631369e-02 | 1.580 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.764932e-02 | 1.558 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.769628e-02 | 1.558 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.866349e-02 | 1.543 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 3.031374e-02 | 1.518 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 3.031374e-02 | 1.518 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.031374e-02 | 1.518 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.062486e-02 | 1.514 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.133015e-02 | 1.504 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 3.154731e-02 | 1.501 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 4.016801e-02 | 1.396 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 4.016801e-02 | 1.396 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 4.016801e-02 | 1.396 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.497986e-02 | 1.456 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.264404e-02 | 1.370 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.295088e-02 | 1.482 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.524851e-02 | 1.453 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.456478e-02 | 1.461 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.456478e-02 | 1.461 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 3.882669e-02 | 1.411 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.884674e-02 | 1.411 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.016801e-02 | 1.396 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.497986e-02 | 1.456 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 3.999416e-02 | 1.398 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.640425e-02 | 1.439 | 1 | 1 |
| Malate-aspartate shuttle | R-HSA-9856872 | 3.497986e-02 | 1.456 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.263028e-02 | 1.370 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 4.063291e-02 | 1.391 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 4.274969e-02 | 1.369 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 3.818579e-02 | 1.418 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.701984e-02 | 1.432 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 3.537979e-02 | 1.451 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.278933e-02 | 1.484 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.373780e-02 | 1.472 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 4.016801e-02 | 1.396 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 3.661936e-02 | 1.436 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 4.276905e-02 | 1.369 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.425735e-02 | 1.354 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.597296e-02 | 1.337 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.638989e-02 | 1.334 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 4.712440e-02 | 1.327 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.842348e-02 | 1.315 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 4.907272e-02 | 1.309 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 4.956300e-02 | 1.305 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.084340e-02 | 1.294 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.104423e-02 | 1.292 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.484232e-02 | 1.261 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 5.524393e-02 | 1.258 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.598073e-02 | 1.252 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.642077e-02 | 1.249 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 5.706568e-02 | 1.244 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 5.706568e-02 | 1.244 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.731346e-02 | 1.242 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 5.895384e-02 | 1.229 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 5.955691e-02 | 1.225 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 5.965997e-02 | 1.224 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 5.965997e-02 | 1.224 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 5.965997e-02 | 1.224 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 5.965997e-02 | 1.224 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 5.965997e-02 | 1.224 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.965997e-02 | 1.224 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 6.194912e-02 | 1.208 | 1 | 0 |
| Immune System | R-HSA-168256 | 6.308107e-02 | 1.200 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 6.340691e-02 | 1.198 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.340691e-02 | 1.198 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.340691e-02 | 1.198 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.408342e-02 | 1.193 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 6.408342e-02 | 1.193 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 6.645122e-02 | 1.177 | 0 | 0 |
| S Phase | R-HSA-69242 | 6.724658e-02 | 1.172 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.963058e-02 | 1.157 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 6.963058e-02 | 1.157 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 6.963058e-02 | 1.157 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 6.963058e-02 | 1.157 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 7.039103e-02 | 1.152 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.039103e-02 | 1.152 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 7.039103e-02 | 1.152 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 7.039103e-02 | 1.152 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 7.039103e-02 | 1.152 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 7.407100e-02 | 1.130 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 7.506580e-02 | 1.125 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 7.553095e-02 | 1.122 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 7.561236e-02 | 1.121 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 7.561236e-02 | 1.121 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 7.661557e-02 | 1.116 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.701053e-02 | 1.113 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 7.701053e-02 | 1.113 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 7.703788e-02 | 1.113 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 1.112500e-01 | 0.954 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 1.112500e-01 | 0.954 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 8.169246e-02 | 1.088 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 8.169246e-02 | 1.088 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 9.350449e-02 | 1.029 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 9.350449e-02 | 1.029 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 9.350449e-02 | 1.029 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 1.057711e-01 | 0.976 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 8.425221e-02 | 1.074 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 8.425221e-02 | 1.074 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 1.076023e-01 | 0.968 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 1.076023e-01 | 0.968 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.158878e-01 | 0.936 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.097594e-01 | 0.960 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.029549e-01 | 0.987 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 9.350449e-02 | 1.029 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 9.350449e-02 | 1.029 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 8.169246e-02 | 1.088 | 1 | 1 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 1.158878e-01 | 0.936 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 1.097594e-01 | 0.960 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.815923e-02 | 1.008 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.148457e-02 | 1.039 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.075656e-01 | 0.968 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 8.169246e-02 | 1.088 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.018599e-02 | 1.096 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.316656e-02 | 1.080 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 8.755122e-02 | 1.058 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 1.112500e-01 | 0.954 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 8.169246e-02 | 1.088 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.037084e-02 | 1.044 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.121242e-01 | 0.950 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.149614e-01 | 0.939 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.574414e-02 | 1.067 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 8.755122e-02 | 1.058 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.574414e-02 | 1.067 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 1.053102e-01 | 0.978 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 8.100850e-02 | 1.091 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.112500e-01 | 0.954 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 8.169246e-02 | 1.088 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.955976e-02 | 1.002 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 9.527223e-02 | 1.021 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 8.116583e-02 | 1.091 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 8.169246e-02 | 1.088 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.057711e-01 | 0.976 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 7.766920e-02 | 1.110 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.158878e-01 | 0.936 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 9.441740e-02 | 1.025 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 9.148457e-02 | 1.039 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 9.350449e-02 | 1.029 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 1.057711e-01 | 0.976 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 1.076023e-01 | 0.968 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 9.177246e-02 | 1.037 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 9.350449e-02 | 1.029 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 9.955976e-02 | 1.002 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 8.169246e-02 | 1.088 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.075656e-01 | 0.968 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.053102e-01 | 0.978 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.152653e-01 | 0.938 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.522139e-02 | 1.021 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 8.315650e-02 | 1.080 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.945922e-02 | 1.048 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 9.177246e-02 | 1.037 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.105445e-01 | 0.956 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.650949e-02 | 1.015 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.161876e-01 | 0.935 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 1.161876e-01 | 0.935 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.161876e-01 | 0.935 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.161876e-01 | 0.935 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.161876e-01 | 0.935 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.161876e-01 | 0.935 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 1.184399e-01 | 0.927 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.184399e-01 | 0.927 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.184399e-01 | 0.927 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.184399e-01 | 0.927 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.184399e-01 | 0.927 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.227763e-01 | 0.911 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.236909e-01 | 0.908 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.244043e-01 | 0.905 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.244043e-01 | 0.905 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.244043e-01 | 0.905 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 1.244043e-01 | 0.905 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.244043e-01 | 0.905 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.244043e-01 | 0.905 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.269796e-01 | 0.896 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.276831e-01 | 0.894 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.314616e-01 | 0.881 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.314616e-01 | 0.881 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.314616e-01 | 0.881 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.314616e-01 | 0.881 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.314616e-01 | 0.881 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.314616e-01 | 0.881 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.325491e-01 | 0.878 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.331391e-01 | 0.876 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.331391e-01 | 0.876 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.335542e-01 | 0.874 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.356636e-01 | 0.868 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.364966e-01 | 0.865 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.385213e-01 | 0.858 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 1.400486e-01 | 0.854 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.455158e-01 | 0.837 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.455158e-01 | 0.837 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 1.455158e-01 | 0.837 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.455158e-01 | 0.837 | 0 | 0 |
| Defective SLC12A1 causes Bartter syndrome 1 (BS1) | R-HSA-5619104 | 1.455158e-01 | 0.837 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 1.455158e-01 | 0.837 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.784625e-01 | 0.748 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.101408e-01 | 0.677 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 2.101408e-01 | 0.677 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 2.101408e-01 | 0.677 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.101408e-01 | 0.677 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 2.101408e-01 | 0.677 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 2.101408e-01 | 0.677 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.101408e-01 | 0.677 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.405995e-01 | 0.619 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.405995e-01 | 0.619 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.405995e-01 | 0.619 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.405995e-01 | 0.619 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 2.405995e-01 | 0.619 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 2.405995e-01 | 0.619 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 2.698854e-01 | 0.569 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 2.698854e-01 | 0.569 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 2.698854e-01 | 0.569 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.698854e-01 | 0.569 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 2.698854e-01 | 0.569 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 2.698854e-01 | 0.569 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.447905e-01 | 0.839 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.722006e-01 | 0.764 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.722006e-01 | 0.764 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.420799e-01 | 0.847 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.420799e-01 | 0.847 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.420799e-01 | 0.847 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 1.512142e-01 | 0.820 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 1.512142e-01 | 0.820 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.512142e-01 | 0.820 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.512142e-01 | 0.820 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.289994e-01 | 0.640 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.434248e-01 | 0.614 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.796537e-01 | 0.746 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.796537e-01 | 0.746 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.578854e-01 | 0.589 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 2.723571e-01 | 0.565 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 1.653887e-01 | 0.781 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.806348e-01 | 0.743 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.205941e-01 | 0.656 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.371926e-01 | 0.625 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 1.743130e-01 | 0.759 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 2.456003e-01 | 0.610 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.626040e-01 | 0.581 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 2.302908e-01 | 0.638 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.798211e-01 | 0.553 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.608965e-01 | 0.793 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 1.605295e-01 | 0.794 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.529886e-01 | 0.815 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.700134e-01 | 0.770 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.700134e-01 | 0.770 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.605295e-01 | 0.794 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 2.195376e-01 | 0.658 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.506337e-01 | 0.822 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.023726e-01 | 0.694 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.722006e-01 | 0.764 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.700134e-01 | 0.770 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.205941e-01 | 0.656 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.374393e-01 | 0.624 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.405995e-01 | 0.619 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 2.297810e-01 | 0.639 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.195376e-01 | 0.658 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.101408e-01 | 0.677 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.447905e-01 | 0.839 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.003601e-01 | 0.698 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 2.401107e-01 | 0.620 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.820810e-01 | 0.550 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.955797e-01 | 0.709 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.420799e-01 | 0.847 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.578854e-01 | 0.589 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 2.505159e-01 | 0.601 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.757046e-01 | 0.755 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.150690e-01 | 0.667 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 2.405995e-01 | 0.619 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.578854e-01 | 0.589 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.769784e-01 | 0.752 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 1.862044e-01 | 0.730 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.698854e-01 | 0.569 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 1.722006e-01 | 0.764 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 2.146351e-01 | 0.668 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 2.820810e-01 | 0.550 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.711887e-01 | 0.567 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.578854e-01 | 0.589 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.434545e-01 | 0.843 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.420799e-01 | 0.847 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.434248e-01 | 0.614 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.003601e-01 | 0.698 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.735438e-01 | 0.563 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 1.455158e-01 | 0.837 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 2.698854e-01 | 0.569 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 2.698854e-01 | 0.569 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 2.698854e-01 | 0.569 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 2.146351e-01 | 0.668 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 2.434248e-01 | 0.614 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.161895e-01 | 0.665 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.232064e-01 | 0.651 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.447905e-01 | 0.839 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.862044e-01 | 0.730 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 2.124149e-01 | 0.673 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.519139e-01 | 0.599 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.605295e-01 | 0.794 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.434248e-01 | 0.614 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.124149e-01 | 0.673 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 2.573457e-01 | 0.589 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.722006e-01 | 0.764 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.993548e-01 | 0.700 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 2.713921e-01 | 0.566 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 1.784625e-01 | 0.748 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.101408e-01 | 0.677 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.101408e-01 | 0.677 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.722006e-01 | 0.764 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.700134e-01 | 0.770 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.796537e-01 | 0.746 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 2.288552e-01 | 0.640 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 2.820810e-01 | 0.550 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 2.713921e-01 | 0.566 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.538869e-01 | 0.595 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.365491e-01 | 0.626 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.579470e-01 | 0.801 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.715112e-01 | 0.566 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.723571e-01 | 0.565 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.505159e-01 | 0.601 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.722006e-01 | 0.764 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 2.723571e-01 | 0.565 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.306100e-01 | 0.637 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.697985e-01 | 0.569 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.434248e-01 | 0.614 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.297810e-01 | 0.639 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.955797e-01 | 0.709 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.559921e-01 | 0.807 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.289994e-01 | 0.640 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.955797e-01 | 0.709 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.538510e-01 | 0.595 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.289994e-01 | 0.640 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.993548e-01 | 0.700 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 2.297810e-01 | 0.639 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 1.455158e-01 | 0.837 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.698854e-01 | 0.569 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.447905e-01 | 0.839 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.722006e-01 | 0.764 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.894381e-01 | 0.723 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.894381e-01 | 0.723 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 2.715112e-01 | 0.566 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.715112e-01 | 0.566 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.594690e-01 | 0.586 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.447905e-01 | 0.839 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 2.798211e-01 | 0.553 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.592328e-01 | 0.586 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.058468e-01 | 0.686 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 2.003601e-01 | 0.698 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.822422e-01 | 0.739 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 2.603982e-01 | 0.584 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 2.603982e-01 | 0.584 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 2.603982e-01 | 0.584 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.475158e-01 | 0.831 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.200342e-01 | 0.658 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.289994e-01 | 0.640 | 1 | 1 |
| Signaling by NOTCH | R-HSA-157118 | 2.283477e-01 | 0.641 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.417055e-01 | 0.849 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 2.820810e-01 | 0.550 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.003601e-01 | 0.698 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.723571e-01 | 0.565 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.917193e-01 | 0.717 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.657358e-01 | 0.781 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.093918e-01 | 0.679 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 2.146351e-01 | 0.668 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.434248e-01 | 0.614 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.092437e-01 | 0.679 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.583835e-01 | 0.800 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 2.628056e-01 | 0.580 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.917193e-01 | 0.717 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 2.609862e-01 | 0.583 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 1.605295e-01 | 0.794 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.401107e-01 | 0.620 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 2.003601e-01 | 0.698 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.372126e-01 | 0.625 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.456003e-01 | 0.610 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 2.715112e-01 | 0.566 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 2.834570e-01 | 0.548 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.868175e-01 | 0.542 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.868175e-01 | 0.542 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 2.868175e-01 | 0.542 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.895381e-01 | 0.538 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.895381e-01 | 0.538 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 2.926859e-01 | 0.534 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.926859e-01 | 0.534 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 2.972077e-01 | 0.527 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.980435e-01 | 0.526 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 2.980435e-01 | 0.526 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 2.980435e-01 | 0.526 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.980435e-01 | 0.526 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 2.980435e-01 | 0.526 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.980435e-01 | 0.526 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.980435e-01 | 0.526 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.980435e-01 | 0.526 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 2.980435e-01 | 0.526 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 2.980435e-01 | 0.526 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 3.033166e-01 | 0.518 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 3.033166e-01 | 0.518 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 3.033166e-01 | 0.518 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 3.033166e-01 | 0.518 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.040665e-01 | 0.517 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.059511e-01 | 0.514 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.059511e-01 | 0.514 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 3.059953e-01 | 0.514 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 3.116594e-01 | 0.506 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 3.138500e-01 | 0.503 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.138500e-01 | 0.503 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 3.139641e-01 | 0.503 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.139641e-01 | 0.503 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 3.156237e-01 | 0.501 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 3.246197e-01 | 0.489 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 3.246197e-01 | 0.489 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 3.246197e-01 | 0.489 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 3.251174e-01 | 0.488 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.251174e-01 | 0.488 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.251174e-01 | 0.488 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.251174e-01 | 0.488 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.251174e-01 | 0.488 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.251174e-01 | 0.488 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.251174e-01 | 0.488 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.251174e-01 | 0.488 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 3.251174e-01 | 0.488 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.251174e-01 | 0.488 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 3.251174e-01 | 0.488 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.251174e-01 | 0.488 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.251174e-01 | 0.488 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 3.251174e-01 | 0.488 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.275008e-01 | 0.485 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 3.279098e-01 | 0.484 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.299330e-01 | 0.482 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 3.299330e-01 | 0.482 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 3.299330e-01 | 0.482 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.299330e-01 | 0.482 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.299330e-01 | 0.482 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 3.299330e-01 | 0.482 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.323198e-01 | 0.478 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.343561e-01 | 0.476 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 3.352749e-01 | 0.475 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.352749e-01 | 0.475 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.412281e-01 | 0.467 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.412281e-01 | 0.467 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 3.422505e-01 | 0.466 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 3.441579e-01 | 0.463 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 3.441579e-01 | 0.463 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.441579e-01 | 0.463 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.441579e-01 | 0.463 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 3.441579e-01 | 0.463 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 3.459218e-01 | 0.461 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 3.459218e-01 | 0.461 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 3.459218e-01 | 0.461 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 3.459218e-01 | 0.461 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 3.459218e-01 | 0.461 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.481145e-01 | 0.458 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.481145e-01 | 0.458 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 3.499646e-01 | 0.456 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.499646e-01 | 0.456 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 3.511487e-01 | 0.455 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 3.511487e-01 | 0.455 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 3.511487e-01 | 0.455 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.511487e-01 | 0.455 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.511487e-01 | 0.455 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.511487e-01 | 0.455 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 3.511487e-01 | 0.455 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 3.511487e-01 | 0.455 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 3.511487e-01 | 0.455 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.511487e-01 | 0.455 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 3.511487e-01 | 0.455 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.511487e-01 | 0.455 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.511487e-01 | 0.455 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 3.511487e-01 | 0.455 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 3.511487e-01 | 0.455 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.516929e-01 | 0.454 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.582837e-01 | 0.446 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 3.582837e-01 | 0.446 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.582837e-01 | 0.446 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.582837e-01 | 0.446 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 3.584536e-01 | 0.446 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.587923e-01 | 0.445 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.597065e-01 | 0.444 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.619212e-01 | 0.441 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.653329e-01 | 0.437 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 3.676175e-01 | 0.435 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 3.688369e-01 | 0.433 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 3.722967e-01 | 0.429 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 3.722967e-01 | 0.429 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.761774e-01 | 0.425 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.761774e-01 | 0.425 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 3.761774e-01 | 0.425 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.761774e-01 | 0.425 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 3.761774e-01 | 0.425 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.761774e-01 | 0.425 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 3.761774e-01 | 0.425 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.761774e-01 | 0.425 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.761774e-01 | 0.425 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.761774e-01 | 0.425 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 3.764358e-01 | 0.424 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 3.764358e-01 | 0.424 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 3.764358e-01 | 0.424 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.777364e-01 | 0.423 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.807403e-01 | 0.419 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.861848e-01 | 0.413 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.861848e-01 | 0.413 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.861848e-01 | 0.413 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 3.861848e-01 | 0.413 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.861848e-01 | 0.413 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.861848e-01 | 0.413 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.896068e-01 | 0.409 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.940343e-01 | 0.404 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.961349e-01 | 0.402 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.999368e-01 | 0.398 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.999368e-01 | 0.398 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 4.002421e-01 | 0.398 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.002421e-01 | 0.398 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.002421e-01 | 0.398 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 4.002421e-01 | 0.398 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 4.002421e-01 | 0.398 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 4.002421e-01 | 0.398 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 4.002421e-01 | 0.398 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 4.002421e-01 | 0.398 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.002421e-01 | 0.398 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.002421e-01 | 0.398 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.028063e-01 | 0.395 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.028063e-01 | 0.395 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 4.078816e-01 | 0.389 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 4.092162e-01 | 0.388 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 4.115549e-01 | 0.386 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 4.135424e-01 | 0.383 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.135424e-01 | 0.383 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 4.191532e-01 | 0.378 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.196056e-01 | 0.377 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.196056e-01 | 0.377 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.196056e-01 | 0.377 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 4.196056e-01 | 0.377 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 4.202763e-01 | 0.376 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 4.213690e-01 | 0.375 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 4.213690e-01 | 0.375 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 4.213690e-01 | 0.375 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.233799e-01 | 0.373 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.233799e-01 | 0.373 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.233799e-01 | 0.373 | 0 | 0 |
| Conjugation of benzoate with glycine | R-HSA-177135 | 4.233799e-01 | 0.373 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.233799e-01 | 0.373 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.233799e-01 | 0.373 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 4.233799e-01 | 0.373 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 4.233799e-01 | 0.373 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 4.233799e-01 | 0.373 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 4.267955e-01 | 0.370 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 4.269926e-01 | 0.370 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.269926e-01 | 0.370 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.299335e-01 | 0.367 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 4.299335e-01 | 0.367 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.299335e-01 | 0.367 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 4.344182e-01 | 0.362 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 4.376228e-01 | 0.359 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 4.379290e-01 | 0.359 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.401947e-01 | 0.356 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.402792e-01 | 0.356 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 4.402792e-01 | 0.356 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 4.402792e-01 | 0.356 | 0 | 0 |
| Disease | R-HSA-1643685 | 4.414049e-01 | 0.355 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 4.420139e-01 | 0.355 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.456264e-01 | 0.351 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.456264e-01 | 0.351 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 4.456264e-01 | 0.351 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 4.456264e-01 | 0.351 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 4.456264e-01 | 0.351 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.456264e-01 | 0.351 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.456264e-01 | 0.351 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 4.456264e-01 | 0.351 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.456264e-01 | 0.351 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.503841e-01 | 0.346 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 4.516268e-01 | 0.345 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 4.516268e-01 | 0.345 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.533946e-01 | 0.344 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.533946e-01 | 0.344 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.533946e-01 | 0.344 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 4.533946e-01 | 0.344 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 4.533946e-01 | 0.344 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.548179e-01 | 0.342 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 4.548179e-01 | 0.342 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 4.548179e-01 | 0.342 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.604971e-01 | 0.337 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.604971e-01 | 0.337 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.604971e-01 | 0.337 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.604971e-01 | 0.337 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 4.633505e-01 | 0.334 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 4.633505e-01 | 0.334 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 4.663325e-01 | 0.331 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 4.663325e-01 | 0.331 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 4.663325e-01 | 0.331 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.670160e-01 | 0.331 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.670160e-01 | 0.331 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.670160e-01 | 0.331 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.670160e-01 | 0.331 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.670160e-01 | 0.331 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.670160e-01 | 0.331 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.670160e-01 | 0.331 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 4.670160e-01 | 0.331 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 4.670160e-01 | 0.331 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.670160e-01 | 0.331 | 0 | 0 |
| Conjugation of salicylate with glycine | R-HSA-177128 | 4.670160e-01 | 0.331 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 4.670160e-01 | 0.331 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.670160e-01 | 0.331 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.670160e-01 | 0.331 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.670160e-01 | 0.331 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.769917e-01 | 0.321 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.778950e-01 | 0.321 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 4.790869e-01 | 0.320 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 4.790869e-01 | 0.320 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 4.790869e-01 | 0.320 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 4.790869e-01 | 0.320 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 4.790869e-01 | 0.320 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 4.790869e-01 | 0.320 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 4.790869e-01 | 0.320 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.804764e-01 | 0.318 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 4.875815e-01 | 0.312 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 4.875815e-01 | 0.312 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 4.875815e-01 | 0.312 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 4.875815e-01 | 0.312 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.875815e-01 | 0.312 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.875815e-01 | 0.312 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 4.875815e-01 | 0.312 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 4.886524e-01 | 0.311 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 4.903346e-01 | 0.310 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 4.903346e-01 | 0.310 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 4.916528e-01 | 0.308 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 4.916528e-01 | 0.308 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 4.923695e-01 | 0.308 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.923695e-01 | 0.308 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.969784e-01 | 0.304 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 5.001002e-01 | 0.301 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 5.031491e-01 | 0.298 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 5.040257e-01 | 0.298 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.040257e-01 | 0.298 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 5.040257e-01 | 0.298 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 5.040257e-01 | 0.298 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 5.040257e-01 | 0.298 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 5.052461e-01 | 0.296 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 5.073547e-01 | 0.295 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 5.073547e-01 | 0.295 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.073547e-01 | 0.295 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.073547e-01 | 0.295 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 5.073547e-01 | 0.295 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.073547e-01 | 0.295 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.073547e-01 | 0.295 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 5.073547e-01 | 0.295 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 5.073547e-01 | 0.295 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 5.073547e-01 | 0.295 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.086828e-01 | 0.294 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 5.090503e-01 | 0.293 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.097699e-01 | 0.293 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 5.097699e-01 | 0.293 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 5.134531e-01 | 0.289 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 5.147682e-01 | 0.288 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 5.162018e-01 | 0.287 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 5.162018e-01 | 0.287 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 5.162018e-01 | 0.287 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.162018e-01 | 0.287 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 5.187108e-01 | 0.285 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 5.193404e-01 | 0.285 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 5.193404e-01 | 0.285 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.193404e-01 | 0.285 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.263660e-01 | 0.279 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.263660e-01 | 0.279 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 5.263660e-01 | 0.279 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 5.263660e-01 | 0.279 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.263660e-01 | 0.279 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 5.263660e-01 | 0.279 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 5.263660e-01 | 0.279 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.263660e-01 | 0.279 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.263660e-01 | 0.279 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.263660e-01 | 0.279 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.281780e-01 | 0.277 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 5.281780e-01 | 0.277 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 5.281780e-01 | 0.277 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.288089e-01 | 0.277 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 5.296756e-01 | 0.276 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 5.328594e-01 | 0.273 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.381726e-01 | 0.269 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 5.399514e-01 | 0.268 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 5.399514e-01 | 0.268 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.446448e-01 | 0.264 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.446448e-01 | 0.264 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.446448e-01 | 0.264 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 5.446448e-01 | 0.264 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.446448e-01 | 0.264 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 5.446448e-01 | 0.264 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 5.446448e-01 | 0.264 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.446448e-01 | 0.264 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 5.456290e-01 | 0.263 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.474290e-01 | 0.262 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 5.515200e-01 | 0.258 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 5.515200e-01 | 0.258 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 5.515200e-01 | 0.258 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 5.515200e-01 | 0.258 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 5.515200e-01 | 0.258 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 5.518827e-01 | 0.258 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 5.573980e-01 | 0.254 | 1 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 5.588452e-01 | 0.253 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 5.622193e-01 | 0.250 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.622193e-01 | 0.250 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 5.622193e-01 | 0.250 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.622193e-01 | 0.250 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.622193e-01 | 0.250 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.622193e-01 | 0.250 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.622193e-01 | 0.250 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 5.628819e-01 | 0.250 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 5.628819e-01 | 0.250 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 5.628819e-01 | 0.250 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 5.740359e-01 | 0.241 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 5.740359e-01 | 0.241 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 5.740359e-01 | 0.241 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 5.740359e-01 | 0.241 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 5.740359e-01 | 0.241 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 5.791165e-01 | 0.237 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 5.791165e-01 | 0.237 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 5.791165e-01 | 0.237 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.791165e-01 | 0.237 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 5.791165e-01 | 0.237 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 5.849812e-01 | 0.233 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 5.849812e-01 | 0.233 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.861406e-01 | 0.232 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.920299e-01 | 0.228 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.928199e-01 | 0.227 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 5.953624e-01 | 0.225 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 5.953624e-01 | 0.225 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 5.953624e-01 | 0.225 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 5.953624e-01 | 0.225 | 0 | 0 |
| PKA activation | R-HSA-163615 | 5.953624e-01 | 0.225 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 5.953624e-01 | 0.225 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 5.953624e-01 | 0.225 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.953624e-01 | 0.225 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 5.957172e-01 | 0.225 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.957172e-01 | 0.225 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 5.957172e-01 | 0.225 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 5.957172e-01 | 0.225 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 6.038269e-01 | 0.219 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.064705e-01 | 0.217 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.064705e-01 | 0.217 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 6.090548e-01 | 0.215 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.109823e-01 | 0.214 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 6.109823e-01 | 0.214 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.109823e-01 | 0.214 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 6.109823e-01 | 0.214 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 6.109823e-01 | 0.214 | 0 | 0 |
| Amino Acid conjugation | R-HSA-156587 | 6.109823e-01 | 0.214 | 0 | 0 |
| Conjugation of carboxylic acids | R-HSA-159424 | 6.109823e-01 | 0.214 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 6.109823e-01 | 0.214 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.109823e-01 | 0.214 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 6.109823e-01 | 0.214 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 6.109823e-01 | 0.214 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 6.109823e-01 | 0.214 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.109823e-01 | 0.214 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 6.165611e-01 | 0.210 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 6.165611e-01 | 0.210 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 6.165611e-01 | 0.210 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 6.165611e-01 | 0.210 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 6.165611e-01 | 0.210 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.187658e-01 | 0.208 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.260001e-01 | 0.203 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.260001e-01 | 0.203 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.260001e-01 | 0.203 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.260001e-01 | 0.203 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.260001e-01 | 0.203 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.260001e-01 | 0.203 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.260001e-01 | 0.203 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 6.260001e-01 | 0.203 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 6.260001e-01 | 0.203 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.260001e-01 | 0.203 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 6.260001e-01 | 0.203 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 6.260001e-01 | 0.203 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 6.266696e-01 | 0.203 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.266696e-01 | 0.203 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.266696e-01 | 0.203 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 6.266696e-01 | 0.203 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 6.266696e-01 | 0.203 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 6.330262e-01 | 0.199 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 6.365700e-01 | 0.196 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 6.367952e-01 | 0.196 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 6.367952e-01 | 0.196 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 6.404390e-01 | 0.194 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.404390e-01 | 0.194 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 6.404390e-01 | 0.194 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 6.404390e-01 | 0.194 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.404390e-01 | 0.194 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 6.404390e-01 | 0.194 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.404390e-01 | 0.194 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.404390e-01 | 0.194 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 6.414592e-01 | 0.193 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 6.418680e-01 | 0.193 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 6.462634e-01 | 0.190 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 6.462634e-01 | 0.190 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 6.543214e-01 | 0.184 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.543214e-01 | 0.184 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.543214e-01 | 0.184 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 6.543214e-01 | 0.184 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 6.543214e-01 | 0.184 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 6.581790e-01 | 0.182 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.650341e-01 | 0.177 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 6.650341e-01 | 0.177 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 6.650341e-01 | 0.177 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.676686e-01 | 0.175 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.676686e-01 | 0.175 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.676686e-01 | 0.175 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 6.676686e-01 | 0.175 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.676686e-01 | 0.175 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.676686e-01 | 0.175 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 6.686409e-01 | 0.175 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 6.686409e-01 | 0.175 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 6.686409e-01 | 0.175 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 6.690533e-01 | 0.175 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.741145e-01 | 0.171 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.741145e-01 | 0.171 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 6.741145e-01 | 0.171 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 6.741145e-01 | 0.171 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 6.805012e-01 | 0.167 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.805012e-01 | 0.167 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 6.829940e-01 | 0.166 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.868809e-01 | 0.163 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 6.916744e-01 | 0.160 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 6.916744e-01 | 0.160 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 6.928390e-01 | 0.159 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 6.928390e-01 | 0.159 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 6.928390e-01 | 0.159 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 6.928390e-01 | 0.159 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 6.928390e-01 | 0.159 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.939878e-01 | 0.159 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.032893e-01 | 0.153 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 7.047011e-01 | 0.152 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 7.047011e-01 | 0.152 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.047011e-01 | 0.152 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.047011e-01 | 0.152 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.161058e-01 | 0.145 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.161058e-01 | 0.145 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 7.161058e-01 | 0.145 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.161058e-01 | 0.145 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 7.165438e-01 | 0.145 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 7.165438e-01 | 0.145 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.184589e-01 | 0.144 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.244508e-01 | 0.140 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 7.270708e-01 | 0.138 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.270708e-01 | 0.138 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 7.270708e-01 | 0.138 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.270708e-01 | 0.138 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.270708e-01 | 0.138 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.270708e-01 | 0.138 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 7.276970e-01 | 0.138 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.376128e-01 | 0.132 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 7.397059e-01 | 0.131 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 7.470594e-01 | 0.127 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.477483e-01 | 0.126 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 7.477483e-01 | 0.126 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 7.477483e-01 | 0.126 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 7.477483e-01 | 0.126 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.542338e-01 | 0.122 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.574929e-01 | 0.121 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 7.574929e-01 | 0.121 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.574929e-01 | 0.121 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.574929e-01 | 0.121 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 7.668616e-01 | 0.115 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.668616e-01 | 0.115 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.668616e-01 | 0.115 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 7.680572e-01 | 0.115 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 7.696999e-01 | 0.114 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.747119e-01 | 0.111 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 7.747119e-01 | 0.111 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 7.747119e-01 | 0.111 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.754823e-01 | 0.110 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 7.754823e-01 | 0.110 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 7.758689e-01 | 0.110 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 7.758689e-01 | 0.110 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.758689e-01 | 0.110 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.811992e-01 | 0.107 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 7.845288e-01 | 0.105 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 7.845288e-01 | 0.105 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.845288e-01 | 0.105 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 7.875222e-01 | 0.104 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 7.908434e-01 | 0.102 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 7.928545e-01 | 0.101 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.928545e-01 | 0.101 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.928545e-01 | 0.101 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 7.928545e-01 | 0.101 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.928545e-01 | 0.101 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.928545e-01 | 0.101 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 7.996871e-01 | 0.097 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.008591e-01 | 0.096 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.008591e-01 | 0.096 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.008591e-01 | 0.096 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.008591e-01 | 0.096 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 8.008591e-01 | 0.096 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.008591e-01 | 0.096 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 8.008591e-01 | 0.096 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.008591e-01 | 0.096 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.017023e-01 | 0.096 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 8.066269e-01 | 0.093 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.085548e-01 | 0.092 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 8.085548e-01 | 0.092 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 8.112307e-01 | 0.091 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 8.114481e-01 | 0.091 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.159535e-01 | 0.088 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 8.167771e-01 | 0.088 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.167771e-01 | 0.088 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.230668e-01 | 0.085 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.230668e-01 | 0.085 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.246371e-01 | 0.084 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.274343e-01 | 0.082 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.299055e-01 | 0.081 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.299055e-01 | 0.081 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.299055e-01 | 0.081 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.299055e-01 | 0.081 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.350386e-01 | 0.078 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.364804e-01 | 0.078 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.364804e-01 | 0.078 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 8.364804e-01 | 0.078 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 8.364804e-01 | 0.078 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 8.423756e-01 | 0.074 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.428014e-01 | 0.074 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 8.428014e-01 | 0.074 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 8.463788e-01 | 0.072 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.488785e-01 | 0.071 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 8.488785e-01 | 0.071 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.488785e-01 | 0.071 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.488785e-01 | 0.071 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 8.504215e-01 | 0.070 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.516748e-01 | 0.070 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 8.516748e-01 | 0.070 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 8.516748e-01 | 0.070 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.547210e-01 | 0.068 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.547210e-01 | 0.068 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.547210e-01 | 0.068 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 8.553709e-01 | 0.068 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.561346e-01 | 0.067 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.603380e-01 | 0.065 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.603380e-01 | 0.065 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 8.603380e-01 | 0.065 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 8.603380e-01 | 0.065 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.603380e-01 | 0.065 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.603380e-01 | 0.065 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 8.629775e-01 | 0.064 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.646889e-01 | 0.063 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 8.653668e-01 | 0.063 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.684411e-01 | 0.061 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.709298e-01 | 0.060 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.709298e-01 | 0.060 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 8.709298e-01 | 0.060 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.727746e-01 | 0.059 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 8.728704e-01 | 0.059 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.759210e-01 | 0.058 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.759210e-01 | 0.058 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.807195e-01 | 0.055 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.807195e-01 | 0.055 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 8.807195e-01 | 0.055 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 8.853327e-01 | 0.053 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 8.853327e-01 | 0.053 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 8.897677e-01 | 0.051 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 8.940315e-01 | 0.049 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 8.940315e-01 | 0.049 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.981306e-01 | 0.047 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 8.998890e-01 | 0.046 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.008589e-01 | 0.045 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.008589e-01 | 0.045 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.013268e-01 | 0.045 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.020714e-01 | 0.045 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.037429e-01 | 0.044 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.039322e-01 | 0.044 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.084187e-01 | 0.042 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.098137e-01 | 0.041 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.098137e-01 | 0.041 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.108413e-01 | 0.041 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.114448e-01 | 0.040 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.118354e-01 | 0.040 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.126265e-01 | 0.040 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.127691e-01 | 0.040 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.127691e-01 | 0.040 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.127691e-01 | 0.040 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.128919e-01 | 0.040 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.130037e-01 | 0.040 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.151572e-01 | 0.039 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.153569e-01 | 0.038 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.227173e-01 | 0.035 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.239867e-01 | 0.034 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.257082e-01 | 0.034 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.282772e-01 | 0.032 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.285836e-01 | 0.032 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.285836e-01 | 0.032 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.296129e-01 | 0.032 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.313478e-01 | 0.031 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.313478e-01 | 0.031 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 9.313478e-01 | 0.031 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 9.313478e-01 | 0.031 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 9.313478e-01 | 0.031 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 9.313478e-01 | 0.031 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 9.313478e-01 | 0.031 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.340052e-01 | 0.030 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.365599e-01 | 0.028 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.365599e-01 | 0.028 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.406744e-01 | 0.027 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.460619e-01 | 0.024 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 9.479263e-01 | 0.023 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.479263e-01 | 0.023 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.499429e-01 | 0.022 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.506485e-01 | 0.022 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.533430e-01 | 0.021 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.555366e-01 | 0.020 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.560339e-01 | 0.020 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.571094e-01 | 0.019 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.572589e-01 | 0.019 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.589145e-01 | 0.018 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.617308e-01 | 0.017 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.620362e-01 | 0.017 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.620362e-01 | 0.017 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.624133e-01 | 0.017 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.648235e-01 | 0.016 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.649210e-01 | 0.016 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.649210e-01 | 0.016 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.691233e-01 | 0.014 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.711951e-01 | 0.013 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.749873e-01 | 0.011 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.763752e-01 | 0.010 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.776303e-01 | 0.010 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.788379e-01 | 0.009 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.798318e-01 | 0.009 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.802350e-01 | 0.009 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.809630e-01 | 0.008 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.809630e-01 | 0.008 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.812674e-01 | 0.008 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.820886e-01 | 0.008 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.853035e-01 | 0.006 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.880506e-01 | 0.005 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.888637e-01 | 0.005 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.895004e-01 | 0.005 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.906271e-01 | 0.004 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.938502e-01 | 0.003 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.969876e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.971048e-01 | 0.001 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.972470e-01 | 0.001 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.975068e-01 | 0.001 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.975872e-01 | 0.001 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.984154e-01 | 0.001 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.986912e-01 | 0.001 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.990090e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.991536e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.993341e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.993842e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.994312e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.997471e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999234e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999378e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999651e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999828e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999934e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999962e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.999993e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999995e-01 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 1 | 0 |